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ABSTRACT 
In the present study, immunohistochemical staining for proliferating cell 
nuclear antigen ^*CNA) in endothelial cells and the quantification of blood vessel 
density by image analysis were used as indices of angiogenesis, and examined in rat 
testes after giving adult animals a single subcutaneous injection of 100 n j hCG and 
during the postnatal development from the age of 10- to 90-day old. 
In response to hCG, a significant increase in the number ofPCNA-positive 
endothelial cells per unit testis section area was found after 24 hours. By 48 hours 
post-injection, it reached a maximum of30-fold above the control before declining to 
levels insignificantly different from basal at 5 days post-injection. The peak ofPCNA-
positive endothelial cells was followed by a significant increase in blood vessel density 
at 3-5 days post-hCG. 
The hCG-induced endothelial cell proliferation was completely abolished 
in adult rats treated with ethane 1,2-dimethane sulphonate to destroy the Leydig cells. 
Chronic Leydig cell suppression by an 8-week treatment with exogenous testosterone 
released from subcutaneous silastic implants was without any significant effect on the 
hCG-induced increase in the number of PCNA-positive endothelial cells per unit 
intertubular area, despite a marked decrease in the level of vascular endothelial 
growth factor immunoreactivity in these cells. No differences could be found between 
the high (25 cm) and the low (3 cm) dose of testosterone implant that could or could 
not maintain near normal levels of spermatogenesis, respectively. Therefore it appears 
that hCG-induced endothelial cell proliferation is dependent on the presence ofLeydig 
cells but less so on their levels of activities or the mass of the seminiferous tubules. 
Leydig cells are probably required, irrespective of their functional states, to mediate 
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the hCG-induced inflammation-like reaction in the testis and the inflammation 
mediators would then directly or indirectly stimulate endothelial cell proliferation. 
Activation of testicular macrophages by intratesticular injection of polystyrene 
latex beads greatly enhanced the effect of hCG in inducing endothelial cell 
proliferation, and the actions of the two appeared to be synergistic. Depletion of 
testicular macrophages by intratesticular injection of liposome-entrapped 
dichloromethylene diphosphonate also potentiated the proliferative response of 
endothelial cells to the injection of hCG, though the effect was less when compared 
with macrophage activation. In the macrophage-depleted testes, the infiltration of 
polymorphonuclear (PMN) leukocytes accompanying the inflammation-like reaction 
to hCG was prolonged and remained evident 2 days post-hCG. These data suggest 
that testicular macrophages may provide a source of angiogenic factors or 
inflammation mediators to potentiate the hCG-induced angiogenic response in the 
testis, and in the macrophage-depleted state, the role of macrophages may be taken 
over by PMN. 
During the postnatal development of the testis, the percentage oftotal testis 
section area occupied by intertubular tissues declined, and it was especially marked 
between the age of 20- and 30-day old. When the number of PCNA-positive 
endothelial cells was normalized against per unit intertubular area, the maximum 
values were found in the testes of 10- to 30-day old rats, which agreed with previous 
observations made in the rat, hamster and mouse using other techniques. This was 
later followed by a peak ofblood vessel density (per unit intertubular area) in 50-day 
old rats. 
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脑 面  m 安 
本實驗採用兩種實驗方法：（1)血管內皮細胞的增殖細胞核抗原 
(proliferating cell nuclear antigen )免疫組織化學染色法，和(2)影像分析軟件 
探測血管密度變化’作爲新生血管增殖的指標。運用以上兩種方法，觀察成年 
大白鼠對人絨毛膜促性腺激素(human chorionic gonadotrophin, hCG) 一次性皮 
下注射弓胞的睪九新生血管變化，以及大鼠出生後10-90曰睪九發育過程中 
新生血管的改變。 
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1.1 Angiogenesis in general 
1.1.1 The concept of angiogenesis 
Angiogenesis is defined as the formation of new blood vessels from pre-
existing vessels. This is one of two recognized processes essential for the 
establishment and maintenance ofvasculature (see reviews by Auerbach & Auerbach， 
1994; Folkman, 1995b; Bicknell, Lewis & Ferrara，1997; Norrby, 1997; Pepper, 
1997; Risau, 1997). The other process - vasculogenesis, is used to describe the 
formation of early vascular plexus from mesoderm by the differentiation of primitive 
precursor cells called angioblasts and it occurs during embryogenesis. After the 
developing embryo has formed a primary vascular plexus, further blood vessels are 
generated predominantly by angiogenesis. 
While vasculogenesis is limited to early embryogenesis, angiogenesis occurs 
not only in embryos but is an important component of tissue growth and development 
during postnatal life. However in adults, angiogenesis rarely occurs under 
physiological conditions except in the female reproductive system where it forms an 
integral part of follicular development, corpus luteum formation, repair of the 
endometrium during the menstrual cycle, formation of the placenta and development 
ofthe breast during pregnancy. Angiogenesis in adults is most commonly associated 
with pathological conditions such as wound healing, inflammation, diabetic 
retinopathy, psoriasis, rheumatoid arthritis, and solid tumor growth (see reviews by 
Folkman, 1995a; Breier et al, 1997; Pepper, 1997). 
1.1.2 The process of angiogenesis 
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Although the exact molecular mechanisms responsible for angiogenesis are not 
known, the cascade of events leading to the formation of new vessels has been well 
documented ^Ianahan & Folkman，1996; Hanahan, 1997; Risau, 1997). The vascular 
growth entails either endothelial sprouting or intussusception. However, microvessel 
growth through sprouting is the predominant type and it develops in the following 
sequence of events. First, there is a local proteolytic degradation of the basement 
membrane and extracellular matrix surrounding the existing vessel. Secondly, there is 
a chemotactic migration of endothelial cells towards the site of angiogenic stimulus. 
As the endothelial cells migrate, they divide and multiply in numbers. A new blood 
vessel begins to take its form when the lumen formation begins either by curvature of 
the endothelial cell or vacuole formation in the cell. Finally, there is the synthesis of 
new basement membrane for anchoring the new blood vessel (see reviews by 
Auerbach & Auerbach, 1994; Hanahan & Folkman，1996). The main target vessels 
for angiogenic stimuli are the postcapillary venules, small terminal venules and 
capillaries (see reviews by Norrby, 1997; Pepper, 1997; Risau, 1997). Among the 
different steps involved in angiogenesis, the demonstration of endothelial cell 
proliferation is most commonly used to indicate the occurrence of this event in vivo 
based on histological examination of tissue sections. In addition, the angiogenic 
potential of tissues, cells or unknown factors can be tested based on their ability to 
induce endothelial cell proliferation or migration using in vitro assays. (Auerbach, 
Auerbach & Polakowski，1991; Jain etal, 1997). 
In the past several years, the identification of a number of well-defined growth 
factors, the observations made from genetically manipulated mice, and the recognition 
ofthe importance ofcell-cell and cell-substrate (e.g. extracellular matrix) interactions 
have greatly expanded our understanding of the regulation of angiogenesis. The 
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actions of a variety of polypeptide growth factors appear to be orchestrated in a 
complex sequence of steps that lead to the new blood vessel formation. The 
communication between the growing vasculature and the tissue parenchyma, as well 
as interactions among the cells in the vessel wall, all appear to influence vascular 
development and growth, (see reviews by Gasparini, 1996; Beck & D，more，1997; 
Breier et al, 1997; Norrby, 1997). 
1.2 Measurement ofangiogenesis 
Angiogenesis can be quantitatively or qualitatively measured using a number 
of different methods. Basically they rely on determining the events (e.g. a step in the 
angiogenic process) or products (e.g. increase in blood vessel density) of 
angiogenesis. Besides there are methods which are less invasive than others and thus 
are more suited for clinical use. 
1.2.1 In vivo assays 
The quantification of angiogenesis in vivo has been performed primarily by 
one of the following three approaches: (1) microcirculatory preparations in animals, 
mostly chick embryo and rodents; (2) vascularization into biocompatible polymer 
matrix implants; and (3) excision of vascularized tissues from animals or human (Jain 
etal, 1997). 
Microcirculatory preparations allow in vivo observation of new vessel 
formation under light microscopy. Based on the methods of preparation, they can be 
divided into three broad categories: (1) chronic transparent chambers (e.g. rabbit ear 
chamber; dorsal skinfold chamber in mice, rats, hamsters or rabbits; cranial windows 
in mice or rats; hamster cheek pouch window); (2) exteriorized tissue preparations 
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[e.g., hamster cheek pouch; mouse, rat, or rabbit mesentery; mouse or rat liver; chick 
chorioallantoic membrane (CAM); air sacs in mice or rats]; and (3) in situ 
preparations (e.g., comeal pocket or iris implant in the eye). With the development of 
computer-assisted image analyses and microvascular technology, considerable 
information regarding the structure and function of new vessels can now be obtained 
using these techniques. 
Vascularization into matrix implants requires a polymer matrix (gel or sponge) 
containing a known amount of angiogenic factor(s) or cells, to be glued or attached to 
a vascular bed. The structure and function of new vessels penetrating the matrix can 
then be measured in a variety of ways. 
With excised tissues, the parameters characterizing angiogenesis are measured 
with a variety of techniques after the vascularized tissue has been excised. The 
techniques for measuring morphologic parameters include light or electron 
microscopy of vascular casts, histological examination of tissue sections stained for 
endothelial cells^asement membrane or perfused with intravascular markers (e.g., 
colloidal carbon, India ink, radioactively labelled red blood cells, high-molecular-
weight tracers). Since endothelial cell proliferation is an essential step in 
angiogenesis, it has been most commonly used as an index of angiogenesis. There are 
a number ofways to identify proliferating endothelial cells (Woosley, 1991)，and these 
include: (a) stereological measurement of increased endothelial cell number in the 
tissue; (b) immunohistochemical staining of proliferating endothelial cells using 
markers such as proliferating cell nuclear antigen ^>CNA) and Ki67 (Linden, et al., 
1992); (c) mitotic figures; and (d) incorporation of tritiated thymidine or 
bromodeoxyuridine during DNA synthesis. However, the histological methods may 
be replaced by various clinically applicable and noninvasive techniques, such as 
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magnetic resonance imaging (MRI), functional computed tomography (FCT) and 
positron emission tomography (PET), as the spatial resolution of the images 
generated using these techniques improves. Angiogenesis in vivo can also be assessed 
qualitatively through the measurement of the plasma or urine concentration of 
angiogenic factors (Cockerill, Gamble & Vadas, 1995; Jain etal.，1997). 
1.2.2 In vitro assays 
Significant insight into understanding the molecular and cellular biology of 
angiogenesis has come from in vitro assays using cultured endothelial cells from 
micro- or macrovessels. Although most angiogenic steps can be studied in vitro, 
research has been focussed on the migration and proliferation of endothelial cells. 
Limited research has been conducted on the dissolution of matrix and differentiation 
of vessels. A sandwich-culture assay has recently been adapted to the study of 
morphogenesis ofblood vessels in vitro in a defined oxygen gradient. The migration 
studies primarily utilize the Boyden chamber or another variant of the under-agarose 
assay. The proliferation studies are based on cell counting, thymidine incorporation 
or staining techniques for cell proliferation (e.g. PCNA) (Auerbach, Auerbach & 
Polakowski, 1991; Jain et al, 1997). Culture conditions for the induction ofhuman 
angiogenesis in vitro using fragments of human placental blood vessel have recently 
been established. Once this novel assay has been validated, it will then be possible to 
examine its ability to detect and screen potential inhibitors and enhancers of human 
angiogenesis OBrown etal., 1996). 
Accurate and reliable quantification of the angiogenic response, both in vivo 
and in vitro, is an essential requirement for the study of new blood vessel growth. 
Over many years, ingenious ways have been developed for measuring this process, 
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and they have contributed much to our present understanding of mechanism of 
angiogenesis. 
1.3 Angiogenic factors 
Since the first isolation of an angiogenic factor from tumors in the early 1970s, 
at least 12 angiogenic factors have been found to stimulate angiogenesis (Folkman & 
Klagsbrun, 1987; Bussolino et al., 1996; Beck & D，more，1997; Iruela-Arispe & 
Dvorak, 1997). Among these angiogenic factors, basic fibroblast growth factor 
(bFGF) is the first to be identified, and it has also been used as a prototype for 
establishing a number of criteria that characterize angiogenic growth factors in 
general. These include their ability to stimulate endothelial cell proliferation in vitro 
or to induce angiogenesis in vivo, and their localization at the sites of vessel growth 
(Iruela-Arispe & Dvorak, 1997). 
Although there are many factors which are known to stimulate angiogenesis, 
majority ofthem are angiogenic only in vivo. This has led Folkman and Haudenschild 
(1980) to propose a distinction between direct and indirect angiogenic factors. 
Direct factors would be those that could elicit angiogenesis, endothelial cell 
migrationy'proliferation both in vitro and in vivo. Indirect factors are those that cannot 
induce angiogenesis on their own in vitro but can do so only in vivo by inducing other 
cells to secrete direct angiogenic factors. 
Among the direct angiogenic factors are the acidic fibroblast growth factor 
(aFGF)�basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF) 
and vascular endothelial growth factor (VEGF). They act directly on endothelial cells 
and are potent stimulators of their proliferation/migration in vitro. However, among 
these few factors, only VEGF has the signal peptide for secretion and also its 
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mitogenic action is specific only to endothelial cells OFerrara, 1996; Ferrara & Davis-
Smyth, 1997). So it makes VEGF a very attractive candidate for the study ofhow the 
angiogenic process is regulated. 
VEGF is a family of heparin-binding, homodimeric glycoproteins OFerrara et 
al., 1992; Dvorak et al,, 1995; Ferrara, 1996; Ferrara & Davis-Smyth，1997). 
Complementary DNA sequence analysis of a variety of human VEGF clones has 
indicated that VEGF may exist as five different isoforms having 121, 145, 165, 189 
and 2 0 6 amino acid residues (VEGFni, V E G F 1 4 5 , VEGFi6s, VEGFi89, V E G F 2 0 6 ) . It 
has now been well established that alternative exon splicing of a single VEGF gene is 
the basis for this molecular heterogeneity. Molecular sizes of VEGF in rodents are 
shorter than the corresponding human species by one amino acid. Due to the 
presence of different isoforms, molecular weight of VEGF ranges from 34-56 kDa. 
All isoforms have the signal peptide for secretion. VEGF proteins may become 
available to endothelial cells by different mechanisms: as freely diffusible proteins 
(VEGF121, VEGFi6s) or after protease activation and cleavage of the longer isoforms 
(VEGFi89, V E G F 2 0 6 , probably also V E G F 1 4 5 ) from their binding to heparin-containing 
proteoglycans on the cell surface, basement membrane or extracellular matrix. VEGF 
is mitogenic only to endothelial cells and it has direct action in vitro to stimulate their 
proliferation. 
1.4 Angiogenesis in the female reproductive system 
In adult tissues, angiogenesis normally occurs under pathological conditions 
such as during inflammation and tissue repair. The female reproductive system is the 
only exception where angiogenesis occurs physiologically as the tissues (i.e. ovarian 
follicle, corpus luteum, postmenstrual endometrium, pregnant uterus and mammary 
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gland) exhibit dynamic cyclical growth and regression (Reynolds, Killilea & Redmer， 
1992; Modlich, Kaup & Augustin, 1996; Gordon et al.，1995; Pepper, 1997; see 
review by Findlay, 1986). In these circumstances angiogenesis is tightly regulated to 
match the metablic demands of the tissues. Many diseases of the female reproductive 
system, including cancers of the female reproductive tissues, endometriosis and 
prolactinomas, also involve angiogenesis (McLaren, et al., 1996; see review by Koos 
& LeMaire, 1983). 
In the ovary, the development of the follicular capillary network may play a 
role in the selection of the dominant follicle, and after ovulation, the rapid 
vascularization of the corpus luteum is crucial to the production of progesterone. In 
concert with the changes in the ovary, angiogenesis within the endometrium must 
occur before implantation and placentation can successfully occur. These new vessels 
supply the nutrients needed for cell growth and biosynthesis in the embryo, and make 
possible the endocrine communication among the ovary, the hypothalamic-pituitary 
unit, and the uterus. 
Ovarian, uterine and placental tissues have been shown to contain and produce 
angiogenic factors (Giudice, 1994; Cooper et al, 1995; Gordon et al, 1995; Gordon 
et al., 1996). Recent evidence also indicates that angiogenesis in the female 
reproductive system is likely to be under the control of the female sex steroids 
(estrogens and progesterone) and gonadotrophins (particularly LH/'hCG) (Chamock-
Jones et al.，1993; Cullinan-Bove & Koo，1993; Dissen et al., 1994; Koos, 1995; 
Hyder et al, 1996; Das et al, 1997) 
1 • 5 Evidence of hormonally-regulated angiogenesis in endocrine tissues 
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Numerous evidence has accumulated in the past which suggests that the 
process of angiogenesis in the female reproductive system is hormonally-regulated 
OFerenczy, Bertrand & Gelfand, 1979; Sato, Ishibashi & Koide, 1982; Koos & 
LeMaire, 1983; Taraska etal, 1989; Dissen etal, 1994; Ferrara et al, 1998). More 
recently, a lot ofthe attention has been directed towards examining the role ofVEGF 
in mediating the hormonally-regulated angiogenesis. VEGF is not only a potent 
angiogenic factor which is mitogenic only to endothelial cells, it also occurs in many 
endocrine glands (e.g. testis, thyroid, pancreas, adrenal and pituitary) (Table 1.1) and 
hormone-responsive tissues like the uterus, fallopian tube, placenta and breast. 
Table 1.1 Occurrence ofVEGF in endocrine glands and hormone-responsive tissues 
Location Cell origin References 
pituitary folliculo-stellate cells Leung et al (1989) 
testis Leydig cells, Sertoli cells Axxetal. (1997) 
ovary granulosa (cumulus) cells, thecal cells; Phillips et al (1990) 
luteal cells ^ ‘ 冬 , / i n n c � 
Kamat et al (1995) 
thyroid follicular cells Sato etal (1995) “ 
pancreas islets p-cells Kuroda etal (1995) 
adrenal adrenal cortex Shweiki etal (1993) 
uterus glandular epithelial cells, stromal cells Torry etal (1996) 
fallopian tube luminal epithelium Gordon etal (1996) 
placenta macrophages, glandular epithelium, Cooper et al (1995) 
trophoblast breast lobular and ductal epithelium Brown et al (1995) 
From those studies examining the involvement of hormones in regulating 
VEGF gene expression andA)r secretion in some of these tissues (mainly the ovary, 
endometrium and thyroid), evidence has been accumulated strongly supporting the 
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possible role of VEGF in mediating hormonally-regulated angiogenesis. Presented 
below are the experimental findings indicating a role of trophic hormones in the 
regulation of VEGF expression, and hence angiogenesis, in the ovary and the thyroid 
gland. 
1.5.1 Ovary 
In the case of the ovary, the role of gonadotrophins in stimulating the 
expression ofVEGF mRNA has been investigated using cultured luteinized granulosa 
cells O^eulen et al., 1995) obtained from human ovarian follicles around the time of 
ovulation when there is a marked increase in follicular angiogenesis. hCG or LH was 
shown to be much more potent than FSH in stimulating VEGF expression in both a 
time- and a dose-dependant manner. Similarly, Laitinen et al. (1997) recently showed 
that recombinant human FSH (rhFSH) can induce an increase in VEGF mRNA levels 
in primary cultures of human granulosa-luteal (GL) cells when the cells were treated 
with rhFSH on days 5-7 of culture. Compared with the effect of hCG/LH, the 
delayed responsiveness to rhFSH was characteristic of this cell culture system. The 
time-course studies indicated that hCG induced a rapid increase in VEGF mRNA 
levels in cultured human GL cells, which was consistent with the results obtained with 
granulosa cells of human origin O F^eulen et al.，1995) and from rats (Koos, 1995). 
VEGF expression has also been examined in monkey corpora lutea by Northern blot 
analysis following GnRH antagonist treatment ^Uvindranath et al, 1992). VEGF 
mRNA levels in corpora lutea obtained from day 7 to 10 of the luteal phase were 
shown to be significantly depressed 3 days after treatment, suggesting that VEGF 
expression in corpus luteum is also dependent on gonadotrophin support. In another 
study, the suppression of gonadotropins release by the administration of a GnRH 
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antagonist significantly suppressed the increase of VEGF mRNA levels in the 
transplanted ovaries obtained from immature rats (Dissen et al., 1994). The use of 
PMSG (pregnant mare serum gonadotropin) to bypass the suppression of endogenous 
FSH levels, failed to restore the VEGF mRNA levels in the transplanted ovary that 
were blunted by the LHRH antagonist. Finally, conditioned medium from 
gonadotrophin-treated human ovarian carcinoma cells was shown to be mitogenic to 
bovine endothelial cells, and this activity was blocked by neutralizing antibodies 
against LH or VEGF (Schiffenbauer et al, 1997). Using RT-PCR, both LH and FSH 
were shown to produce a dose-dependent stimulation ofVEGF expression in cultured 
human ovarian cancer spheroids. Based on above findings, it can be concluded that 
the stimulation of gonadotrophins, mainly LH/hCG, is involved in the regulation of 
VEGF mRNA levels in the ovarian follicles and corpora lutea, and thus may provide 
the basis for a hormonally-induced angiogenesis in the ovary. 
1.5.2 Thyroid 
Similar to the trophic effects of gonadotrophins on ovarian VEGF expression, 
in the thyroid gland, VEGF mRNA levels in cultured human thyroid follicles can be 
stimulated by thyroid stimulating hormone (TSH) (Sato et al, 1995). The TSH effect 
can be mimicked by thyroid stimulating immunoglobulin (TSI) from Graves' disease 
patients, resulting in an even greater stimulation of VEGF mRNA levels than TSH. 
Furthermore a cell permeable analogue of cAMP (dibutyryl cAMP) can mimick the 
effects ofTSH and TSI and produces a dose-related stimulation of VEGF expression 
in the same system of cultured human thyroid follicles (Sato et al, 1995). Since TSI 
is an autoantibody against TSH receptor, and its binding to TSH receptor activates 
the same intracellular signalling transduction cascade (i.e. cAMP-protein kinase A 
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pathway) as that of TSH or this can be mimicked by exogenous cAMP analogues, 
thus the above data strongly support a role for TSH in the control of VEGF 
expression in the thyroid gland. Another study also showed that in three out of four 
thyroid cancer cell lines that were tested, TSH stimulated a significant increase in 
VEGF release as measured using ELISA (Soh et al, 1996). Recently Viglietto et al. 
(1997) reported that VEGF mRNA expression was markedly enhanced in biopsies of 
goiters resected from Graves's patients. In vivo studies demonstrated that in the 
thyroid gland of thiouracil-fed rats, increased VEGF mRNA levels occurred 
subsequent to the compensatory rise in the serum TSH levels and in parallel with 
thyroid capillary proliferation. These data suggested that VEGF, released from 
thyrocytes in response to the chronic stimulation by TSH, may act through a paracrine 
mechanism to increase endothelial cell proliferation and hence blood vessel growth in 
the thyroid gland (Viglietto et al,, 1997). So in summary, the above data indicate that 
in response to TSH or TSI, normal thyroid cells as well as thyroid carcinoma cell lines 
can increase the VEGF expression. The combined results from in vivo and in vitro 
studies demonstrated that activation of the intracellular signalling transduction 
cascade linked to TSH binding to its receptors may trigger and maintain the dramatic 
hypervascularization of the thyroid gland through a coordinated regulation of VEGF 
expression in thyrocytes. 
1.6 Angiogenesis in the testis 
1.6.1 Structure of testicular vasculature 
The vascular system of the testis possesses several peculiar anatomical 
features which indicate that it has important control over the function of the testis (see 
reviews by Free, 1977; Desjardins, 1989，1993; Bergh & Damber, 1993; Setchell, 
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Maddocks & Brooks, 1994). These include a long unbranched testicular artery, the 
presence of a peritubular and an intertubular capillary network, the lining of the 
testicular vasculature by an unfenestrated endothelium and the failure of the capillaries 
to penetrate the seminiferous tubules. Due to the haemodynamic properties from a 
long unbranched vessel, testicular artery is considered to pose an upper limit on the 
rate ofblood flow through the testis. The two testicular capillary networks have been 
proposed to offer an independent control ofblood flow to the tubular and intertubular 
compartments of the testis. The peritubular capillaries vascularize the seminiferous 
tubules, whereas the intertubular capillaries preferentially supply and drain the 
testicular interstitium. An unfenestrated endothelium may impede the passage of 
important macromolecules like the gonadotrophins, from blood to the target cells 
within the testis. Finally the seminiferous tubules which made up the bulk of the 
testicular tissues and contain numerous actively dividing and differentiating germ cells, 
do not have a direct blood supply. Since oxygen has to diffuse from the capillaries in 
the intertubular areas to the seminiferous tubules, the centre of these tubules has been 
shown to be at the brink of hypoxia. In the view of the limitations imposed by the 
anatomical arrangement of the testicular vasculature, a well-developed and maintained 
blood supply appears to be extremely important to the normal activities within the 
testis and may provide the necessary local control of testicular function. In the 
vascular control within the testis or any other major organs, besides the acute effects 
from the alteration of the vascular permeability, and the regulation of blood flow by 
vasodilation or vasoconstriction, there is a medium- to long-term regulation by 
controlling the blood vessel formation or angiogenesis. 
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1.6.2 Angiogenic factors in the testis 
It remains to be elucidated how the angiogenic process in the testis is initiated 
and controlled. Nevertheless, the two major somatic cell types within the testis, 
namely the Leydig cells and Sertoli cells, have been shown to produce or contain 
potent angiogenic factors (Table 1.2). Besides, the testis contains a resident 
population of white blood cells _ macrophages, mast cells and lymphocytes, which 
may also play a role in the process of angiogenesis through their secretory products 
(Table 1.2 and 1.3). 
Resident macrophages comprise up to 25% of the interstitial cell population in 
the testis of mammals including man, monkey, rat and boar (Kern et al. 1995). There 
are numerous reports demonstrating a significant interaction between Leydig cells and 
testicular macrophages within the testis (Miller, Bowman, & Rowland 1983; Bergh, 
1985). This has led to the speculation that testicular macrophages are also involved in 
the process of angiogenesis within testis. 
The macrophage is the major terminally differentiated cell type of the 
mononuclear phagocyte system. Its origin lies in the bone marrow. Once the 
monocytes migrate from the blood circulation into the extravascular tissues, they 
terminally differentiate into tissue macrophages, and remain resident in their organ 
sites. In general, macrophages also represent a cellular source of angiogenic factors. 
In vitro and in vivo studies have shown that macrophages produce a variety of 
angiogenic factors (Table 1.3) depending upon their state ofactivation (Sunderkotter 
et al, 1991; Polverini, 1995). They can promote angiogenesis by two possible 
mechanisms: (a) influencing endothelial cell proliferation and differentiation, and/or 
(b) modifying the production of extracellular matrix components (Sunderkotter et al, 
1991; Leek, Lewis & Harris 1997). 
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Table 1.2 Angiogenic factors, cytokines and mediators of angiogenesis present in 
mammalian testes* 
Substances Species " ^ S W ” “ d e t e c t i o n ” Control ofproduction 
localization method ofexpression 
EGF Mouse Sertoli cells ^ C  
~ " b P ^ R ^ Sertoli cells RPA, Westem FSHfl 
bFGF R ^ ~ Leydig cells mC, RPA  
~ 5 5 C T ^ Leydig cells fflC, R P A , ~ hCGft 
Northern  
~"PDCT 1 ^ Sertoli cells RPA, bioassay, FSHU 
Northern 
XGFa ^ ~ Sertoli cells Northern, Western  
~ T G F a 5 S ~ " Leydig cells ^ C  
~ ^ f ^ ^ Sertoli cells RPA, Northern, FSHU 
Westem, m C  
TGFP R ^ ~ Leydig cells ^ C  
XNFa ^ ~ macrophages Bioassay LPSft  
VEGF human Sertoli cells Western, MC, RT-PCR  
VEGF human Leydig cells Western, fflC, RT-PCR  
~ A T ^ I S Leydig cells RIA/HPLC — 
n]Il R ^ Sertoli ce l l s“ Bioassay LPSft  
^ 1 E^t Leydig cells Northern D -^lp，LPS, hCGfl 
5 ^ Rat Macrophages Bioassay 
SP human Leydig cells JHC 
* M part modified from Ergun et al (1997); Gnessi, Fabbri & Spera (1997) and Norrby 
(1997). 
Abbreviations for substances: EGF: epidermal growth factor; bFGF: basic fibroblast growth 
factor; PDGF: platelet-derived growth factor; TGFp: transforming growth factor p; TNFa: 
tumornecrosis factor a; AT-II: angiotensin-II; IL-1: interleukin-l; SP: substance P. 
介-stimulates or increases; ^ - inhibits or decreases. 
HPLC high pressure liquid chromatography; mC: immunohistochemistry; RIA: 
radioimmunoassay; RPA: ribonuclease protection assay; RT-PCR: reverse transcriptase-
polymerase chain reaction; Northern: Northern blot analysis; Westem: Westem blot analysis. 
FSH: follicle stimulating hormone; hCG: human chorionic gonadotrophin; LPS: 
lipopolysaccharide. 
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Table 1.3 Macrophage-derived factors involved in angiogenesis 
Mitogens 
Basic Fibroblast growth factor (bFGF) 
Epidermal growth factor (EGF) 
Transforming growth factor-a (TGF-a) 
Insulin-like growth factor I and II (IGF-I and -II) 
Vascular permeability factor / Vascular endothelial growth factor 
Migration inducing factors 
Angiotropin 
Human angiogenic factor (HAF) 
Diverse angiogenic factors derivedfrom macrophages 
Angiotensin converting enzyme (ACE) 




Interleukin 6 (EL-6) 
Platelet-derived growth factor / thymidine phosphorylase (PDGF / TP) 
Prostaglandins 






Factors with complex effects 
Transforming growth factor-P (TGF-P) 
Tumor necrosis factor-a (TNF-a) 
* Modified from Sunderkotter etaI. (1991) and Leek, Lewis & Harris (1997) 
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So within the testis, angiogenic cytokines and other factors can be produced 
by a wide range of cell types, including Leydig cells, Sertoli cells, macrophages, mast 
cells, endothelial cells, and fibroblasts. These cells and their products may have 
complex interactions to control the angiogenic process. 
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1.6.3 Vascular effects of hCGfLH in the testis 
The effect of hCG on the testicular vasculature has been well-documented. A 
single subcutaneous injection of 50-100 RJ hCG in adult rats results in an initial 
decrease followed by an increase in testicular blood flow together with a change in the 
pattern ofvasomotion (Setchell & Sharpe，1981; Widmark, Damber & Bergh，1986; 
Widmark et al, 1987; Bergh, Damber & Widmark^ 1988; van Vliet et al, 1988). 
Accompanying the changes of blood flow, there is an inflammation-like increase in 
vascular permeability and polymorphonuclear leukocyte infiltration (Sharpe, 1979; 
Sharpe & Cooper, 1983; Bergh etaI., 1986，1987; Widmark, Damber & Bergh, 1986; 
Widmark et al,, 1987). Similar responses may be induced in human testes (Hjertkvist 
et al., 1993) and with the use o fLH (Widmark, Damber & Bergh，1989; Bergh, 
Damber & Widmark, 1990). Such vascular changes seen in the testis in response to 
LHAiCG are very similar to the inflammatory reaction and changes of blood flow in 
the ovulatory follicle exposed to the pre-ovulatory gonadotrophin surge OEspey, 1980; 
Gerdes et al, 1992). Despite the similarity between the two events, no previous 
studies have attempted to examine whether the angiogenesis in the ovulatory follicles, 
which is most likely also linked to the gonadotrophin stimulation, could similarly be 
induced in the testis by LH/hCG. 
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1.6.4 Postnatal development oftesticular vasculature 
Although angiogenesis is equally important to the developing testis pre- and 
post-natally, the angiogenic process in the postnatal testis has not been well examined. 
In the testes of newbom rats, intratesticular blood vessels are poorly developed, 
fragile to pressure, highly permeable to dyes and not organized in their relation to 
interstitial cells or seminiferous tubules (Kormano, 1967a，b). Within the first 15 days 
ofpostnatal life, little organization ofthe blood vessels takes place as indicated by the 
result of a microangiographic study (Kormano, 1967a). The organization into the 
mature capillary network, consisting of intertubular capillaries and peritubular 
capillaries, develops between the ages of20 and 35 days (Komamo, 1967a). Another 
study examined the ultrastructural aspects of the developing testicular 
microvasculature in immature golden hamsters and compared with that in adult 
hamsters (Mayerhofer & Bartke, 1990). Angiogenic process, as indicated by the 
presence of migrating endothelial cells, is most conspicuous between days 8 and 25 of 
postnatal development, almost absent on days 30 and 35 and not detected in the testes 
of 3-month-old hamsters. This study also indicates that the formation of intertubular 
capillaries precedes the development of peritubular vessels. This general sequential 
pattem in the development of the testicular microvessels is in accordance with results 
of a previous microangiographic study on the postnatal formation of testicular 
microvasculature in the rat testis (Komamo, 1967a). In another study, the population 
of endothelial cells in mouse and rat testes appears to develop in a similar fashion 
except for the fact that the major increase in the number per testis occurs somewhat 
earlier in mice than in rats (day 18 and day 21, respectively) (Hardy, Zirkin & Ewing， 
1989). The endothelial cells show a more or less constant proliferative activity after 
birth (Vergouwen et al., 1991) at a level which is somewhat higher than that of the 
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other interstitial cells. The level of proliferative activity is probably enough to account 
for the observed increase in the number of endothelial cells and the growth of new 
blood vessels within the testis. 
1.7 Aims ofthe present study 
The aims of the present study are to use endothelial cell proliferation as an 
index of angiogenesis (a) to examine whether this parameter is stimulated in adult rat 
testes following the exposure to a single dose ofhCG, and how this may be related to 
the presence or the activity ofLeydig cells and testicular macrophages, and the levels 
of spermatogenesis in the seminiferous tubules, and (b) to examine how the magnitude 
of this parameter will change during the postnatal development of the rat testes. In 
some experiments, the changes in the number of proliferating endothelial cells will be 
related to the blood vessel density within the testis. In addition, testis weight and 
their serum testosterone concentration will also be measured in the animals used in 
these studies. 
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2. Materials and methods 
2.1 Animals 
Male Sprague-Dawley rats were used and they were obtained from the Animal 
House, The Chinese University of Hong Kong. They were maintained under a 
controlled environment of21 士 2。(：，humidity below 75%, and a 12 h light (06:00h -
18:00h) / 12 h dark (18:00h - 06:00h) cycle. The animals had free access to rat chow 
and tap water. 
Adult rats used in this study were about 90 days old and had a body weight 
range of400-450g. In the age study, animals of specific ages were used and the day 
ofbirth was taken as the age ofday 1. 
2.2 Experimental designs 
2.2.1 Testicular angiogenesis in adult rats - hormonal stimulation by hCG 
2.2.1.1 Changes with time after hCG treatment 
In the treatment groups, each animal received a single subcutaneous injection 
of 100 JU hCG 0?regnyl, Organon, Netherland) in 0.2 ml phosphate-buffered saline 
^>BS) containing 0.01% bovine serum albumin (BSA) ^'raction V，protease-free; 
Sigma Chemicals Co., St. Louis, MO, USA) as the carrier protein. The timing of 
hCG injection was such that the animals were killed on the same day at various times 
ranging from 12 hours to 7 days post-hCG injection OFigure 2.1). The control group 
was injected with 0.2 ml vehicle (saline containing 0.01% BSA) 24 hours before being 
killed. All animals were killed by decapitation and trunk blood was collected for the 
measurement of serum testosterone concentration by radioimmunoassay. Both testes 
were collected and weighed before one was perfused with fixative (i.e. Bouin 
solution) and the other with Lidian ink (Staedtler, Numberg, Germany) for the 
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Figure 2.1 Experimental design used in the study of the effect o f a 
single subcutaneous injection of 100 RJ hCG on endothelial cell 
proliferation in adult rat testes. The animals were examined over a period 
ranging from 12 hours to 7 days post-hCG. 
21 
quantification ofproliferating endothelial cells and blood vessel density, respectively. 
Other details on the fixation and processing of the testes are described later. 
2.2.1.2 Effect ofLeydig cell depletion 
In order to investigate whether Leydig cells are involved in mediating the 
angiogenic response of the testis to hCG, ethane-l,2-dimethane sulphonate OEDS; 
synthesized by the Chemistry Department, The Chinese University of Hong Kong) 
treatment was used to selectively destroy the Leydig cells (Jackson & Jackson^ 1984). 
EDS was dissolved in a dimethylsulphoxide pMSO):water mixture (1:3 v/v) to a 
concentration of75 mgAnL Rats were injected intraperitoneally with a single dose of 
EDS (75 mg/kg bw) or the vehicle ODMSO:water) 3 days prior to receiving a single 
subcutaneous injection of 100 RJ hCG (or saline or the treatment control) and studied 
at 1 and 2 days post-hCG. Details of the experimental design are shown in Figure 
2.2. At the time when the rats were killed by decapitation, trunk blood was collected 
for the measurement of serum testosterone concentration by radioimmunoassay, and 
testes were removed and processed for immunohistochemical localization of 
proliferating endothelial cells (details given later). 
2.2.1.3 Effect ofLeydig cell suppression by subcutaneous testosterone-filled silastic 
implants 
Rats received subcutaneous testosterone-fiUed silastic implants ^)ow Coming, 
602-305; i.d. 1.98 nun, o.d. 3.18 mm) of either 3 cm or 25 cm in length for eight 
weeks to achieve Leydig cell suppression. The two lengths of testosterone implants 
were chosen based on the fact that the 3 cm implant would produce normal levels of 
serum testosterone ^lobaire et al., 1979) but could not provide adequate hormonal 
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Figure 2.1 Experimental design used in the study of the effect of a 
single subcutaneous injection of 100 JU hCG on endothelial cell 
proliferation in adult rat testes. The animals were examined over a period 
ranging from 12 hours to 7 days post-hCG. 
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support to maintain normal spermatogenesis, while the 25 cm implant would maintain 
near normal levels ofspermatogenesis but in the presence of supraphysiological levels 
ofcirculating testosterone (Sun et al., 1989; McLachlan et al., 1994). Age-matched 
animals without bearing any subcutaneous silastic implants were used as the control. 
After 8 weeks oftreatment, halfthe number of animals in the control and treatment 
groups received a single subcutaneous injection of 100 KJ hCG while the other halves 
were injected with saline. They were killed 2 days post-hCG (or saline) for the 
quantification of proliferating endothelial cells in the testes and for the measurement 
of serum testosterone concentration. Details of the experimental design are shown in 
Figure2.3. 
2.2.1.4 Effect oftesticular macrophage activation 
Testicular macrophages were activated by intratesticular injection of 
polystyrene latex beads according to the procedure described by Kerr & Sharpe 
(1989). Under light ether anaesthesia, rats were given a unilateral intratesticular 
injection of 2% polystyrene latex beads (0.8 i^m diameter, Sigma) in 150 ^1 sterile 
saline into the central part of the right testes, and 150 p,l sterile physiological saUne 
into the contralateral testes. Three days later, half of the animals were injected 
subcutaneously with 100 RJ hCG while the rest were injected with saline and served 
as the corresponding control. The animals were studied at 1- and 2-day post-hCG. 
Sera were collected for the measurement of testosterone concentration and testes 
were fixed for histological examination and quantification of proliferating endothelial 
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Figure 2.3 Experimental design used in the study of the effect of 
Leydig cell suppression by 3 cm or 25 cm testosterone (T) - filled 
subcutaneous silastic implants on hCG-induced endothelial cell 
proliferation in adult rats testes. The animals were examined at 2 
days post-hCG. 
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were examined at 1 day and 2 days post-hCG. 
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2.2.1.5 Effect of testicular macrophage depletion 
Testicular macrophage depletion was achieved by intratesticular injection of 
liposome-entrapped dichloromethylene diphosphate (Cl2MDP-lp) according to the 
method described by Bergh et al. (1993a & b). Cl2MDP was a gift from Boehringer-
Mannheim GmbH (Germany) and the preparation of Cl2MDP-lp was described in a 
later section. Under light ether anaesthesia, the animals received bilateral 
intratesticular injection of 150 i^l Cl2MDP-lp per testis for the treatment group or 150 
|il liposome encapsulated phosphate bufFered-saline (PBS-lp) per testis for the control 
group using a 27 gauge hypodermic needle. The injection was given through the 
scrotal skin and the scrotal sac (i.e. tunica vaginalis) without exposing the testes. 
After identifying the outline of the testis undemeath the scrotal skin, the tip of the 
needle was inserted into the central part of the testis and the injection was carried out 
slowly over a period of20 seconds. Two weeks after Cl2MDP-lp treatment (or sham 
injection) when in the previous report, the numbers of testicular macrophages were 
found to be at its lowest (Bergh, Damber & van Rooijen, 1993a)，half of each group 
was injected subcutaneously with 100 KJ hCG while the remaining halfwas injected 
with saline. On the same day, all animals received intraperitoneal injection of 3% 
trypan blue in saline (0.75 mVkg bw) to label the testicular macrophages O^iemi, 
Sharpe & Brown^ 1986)，ifany, that were present. Two days post-hCG, the rats were 
killed by decapitation for the collection ofsera and testes. Details of the experimental 
design are shown in Figure 2.5. 
2.2.2 Developmental changes in testicular angiogenesis 
Rats of specific ages (10，20, 30, 40, 50, 60 and 70 days old) were used and 
they were killed by decapitation. Trunk blood was collected for the measurement of 
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Figure 2.5 Experimental design used in the study of the effect of 
testicular macrophage depletion by liposome-entrapped 
dichloromethylene diphosphonate (Cl2MDP-lp) treatment on hCG-
induced endothelial cell proliferation in adult rat testes. The animals 
were examined at 2 days post-hCG. 
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serum testosterone. Testes were perfused with Bouin solution or Indian ink before 
being processed for immunohistochemical staining of proliferating endothelial cells or 
quantification ofblood vessel density, respectively. Li younger animals (10-30 days 
old), the descending aorta was cannulated for lower body perfusion to fix the testes or 
to infuse with Indian ink. In older animals, the testes were excised and weighed 
before being perfused through the testicular subcapsular artery. The data obtained 
from this study were examined together with values obtained from normal adult rats 
of about 90 days of age. 
2.3 Perfusion oftestes with fixative or Indian ink 
In adult and 40-70 days old rats, testes were excised (without the 
epididymides) and weighed after the animals were killed by decapitation. Using a 
scapel blade (size #24, Swann-Morton, Sheffield，England), a small cut was made in 
the testicular subcapsular artery close to where it enters the tunica albuginea at the 
cranial pole ofthe testis and along its course down the epididymal margin ofthe testis. 
A cannula constructed from a polythene tubing (0.5 mm i.d., 1.0 mm o.d., 
800/110/160, Portex, UK) and heat-drawn to a tip diameter of about 100 i^m 
diameter was inserted into the subcapsular artery along the direction of normal flow. 
One to two millilitres ofpre-warmed (25-30�C) heparinized saline (50 U/ml in normal 
saline; sodium salt ofheparin from porcine intestinal mucosa; Sigma, USA) were then 
infused through the cannula into the testis by hand using a 5 ml syringe fitted with a 
gauge 23 needle (Terumo, Tokyo, Japan), until all the blood was flushed out. The 
saline infusion was then followed by 1.5-2.0 ml of Bouin fixative or Indian ink 
depending on whether the tissue was subsequently used for the quantification of 
proliferating endothelial cells or blood vessel density, respectively. In the infusion, 
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care was taken to prevent the entry of any air bubbles, and the volume ofinfusate was 
adjusted until there were a complete removal of blood and a uniform distribution of 
the fixative/ink. The perfused testes were then immersion-fixed in Bouin solution for 
24 hours at room temperature, followed by another 24 hours at 4°C. After the first 24 
hours, the testes were cut using microtome blades (S35, Feather, Japan) into 2 mm 
thick slices at right angle to the cranial-caudal axis. 
For 10 to 30 days old rats, testes were perfused in situ after cannulating the 
descending aorta. Under ether anaesthesia, the thoracic cavity of the animal was cut 
open to expose the descending aorta behind the right lung. A cannula constructed 
from a polythene tubing (0.5 mm i.d., 1.0 mm o.d., 800/110/160，Portex, UK) was 
inserted into the aorta through a small incision and tied in place using surgical sutures 
(4.0，Pearsalls, England). Pre-warmed heparinized saline (25-30�C) was infused using 
a syringe pump fitted with a 5 ml syringe at a rate of 0.8 ml per minute. After the 
blood was removed, Bouin fixative or Indian ink (about 2 ml per animal) was infused 
at the same rate. After perfusion, the testes were removed and immersion-fixed in 
Bouin solution for 2 days as described above. The testes were bisected after 24 hours 
at right angle to the cranial-caudal axis. 
2.4 Processing of the testes for histological sections 
After fixation, the testes were transferred to 70% alcohol and washed by 
several changes to remove the picric acid left in the tissue from the Bouin fixative. In 
the subsequent steps of tissue processing, a slice of tissue (about 2 mm thick) was 
taken from the central part of each testis and put through a tissue processor 
pepartment ofAnatomy, The Chinese University ofHong Kong) for dehydration in 
alcohol, clearing in xylene and embedding in paraplast ^>araplast X-TRA, melting 
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point 50-54�C，Oxford Labware, St. Louis, MO, USA). The timing of the above 
steps differed depending on the size of the testis (i.e. the age of the rats from which 
the testes were obtained) and it ranged from 30 min to 1 hour with 3 changes of 
absolute ethanol and 2 changes ofxylene. Serial sections (5^lm thick) were prepared 
using a microtome QsAodel 1130，Biocut, Reichert-Jung, Germany) and every tenth 
section was mounted on a glass slide coated with 1% 3-aminopropyltriethoxysilane 
(APES) (Sigma) in ethanol OV[addox & Jenkins, 1987). 
2.5 Immunohistochemical staining for proliferating cell nuclear antigen OPCNA) 
To examine the changes in the levels of testicular angiogenesis, 
immunohistochemical staining for proliferating cell nuclear antigen (PCNA) was used 
as a marker to identify the number of proliferating endothelial ceUs, which in tum was 
taken as an index of angiogenesis. 
Reagents used for immunohistochemical staining were from Zymed 
Laboratories Inc. (South San Francisco, USA) and they are based on the streptavidin-
biotin-peroxidase system. The procedure was carried out according to 
manufacturer's instructions with some modifications. Paraplast-embedded 5 fim 
testis sections were dewaxed in OR)-(+)-limonen O^erck, Germany) and rehydrated 
through a down series of ethanol and finally equilibrated in 10 mM phosphate-
bufFered saline ^>BS, pH 7.4). The same buffer was used in subsequent washes (3 
times, 2 min each) between steps and in the dilution of antibodies and reagents except 
the chromogen. The tissue endogenous peroxidase activity was quenched by 
treatment with 3% H2O2 O^erck, Germany) in PBS for 10 min. Sections were then 
incubated overnight at 37°C with a mouse monoclonol antibody against PCNA (Clone 
PC10, IgG2a subclass, Dako, Denmark) at a 1:100 dilution in PBS containing 10% 
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foetal calf serum (Gibco, MD, USA) to block non-specific binding. This was 
followed by 10 min incubation with a biotinylinated goat anti-mouse IgG ^I+L) 
second antibody at a dilution of 8 ^ig/ml. The second antibody binding was 
subsequently localized by incubating the sections for 10 min with horseradish 
peroxidase-conjugated streptavidin at 1:400 dilution. The peroxidase label was then 
visualized by developing the sections for 15-30 min in acetate buffer containing 3-
amino-9-ethylcarbazole (AEC) in N,N-dimethylformamide and 0.03% H2O2. After 
thorough rinsing with distilled water, the sections were mounted in an aqueous 
mounting medium - polyvinyl pyrrolidone (Bancrofts & Stevens, 1996) without 
counterstaining with haematoxylin. 
In validating this method for the immunostaining of PCNA in testis sections, 
both the omission of the primary antibody and its replacement by pre-immune mouse 
immunoglobulin of the same isotype (mouse IgG2a, Clone GC270, Serotec, UK) had 
been tested as the negative controls. No non-specific or background staining could be 
detected. 
2.6 Immunohistochemical staining for vascular endothelial growth factor 
In studying the effect ofLeydig cell suppression on hCG-induced endothelial 
cell proliferation in adult rat testes, the levels of immunoreactivity of an angiogenic 
factor - vascular endothelial growth factor (VEGF), localized in Leydig ceUs and 
Sertoli cells ofthe rat testis (Au et al., 1997) were examined by immunohistochemical 
staining. The methods were the same as those earlier described for PCNA with some 
minor modifications. After blocking the endogenous peroxidase activity, the testis 
sections were subjected to an antigen retrieval procedure in which the slides were 
boiled in 0.01 M citrate buffer (jpH 4.1) for 20 min at 95°C and then left to cool in the 
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same buffer for 20 min at room temperature. The VEGF antibody used in this study 
was commercially available (Santa Cruz Biotechnology, Santa Cruz, CA, USA). It is 
an affinity-purified rabbit polyclonal antibody raised against a synthetic peptide which 
corresponds to amino acids 1-20 at the amino terminus of VEGF. This region of 
VEGF is common among the different isoforms. Previous studies had reported the use 
of this antibody in the immunhistochemical staining of VEGF in rat tissues (CoUin & 
Bergh, 1996). The VEGF antibody was used at 1:200 dilution and incubated with the 
section for 1 hour at room temperature. The second antibody was a biotinylated 
goat-anti-rabbit IgG 0^+L) used at a dilution of 8 ^g/ml. After immunostaining, the 
sections were counterstained with haematoxylin. 
2.7 Quantification ofPCNA-positive endothelial cells 
Proliferating cells were identified based on the positive nuclear staining for 
PCNA. Since within the intertubular areas of the testis, there were other cell types 
which could divide and hence stained positive for PCNA (e.g. Leydig cells, 
macrophages, vascular smooth muscle cells, pericytes), the endothelial cells were 
distinguished according to the criteria described by Hardy et. al (1989). Endothelial 
cells are fusiform cells with cytoplasmic extensions that form the walls of the blood 
vessels. Although these cells are in intimate contact with pericytes, the two can be 
distinguished because pericytes are located outside of the vessel, and as weU their 
nuclei typically bulge away from the lumen of the vessel. In contrast, the nucleus of 
the endothelial cell bulges inward and deflects the circular contour of the vessel 
lumen. 
The number of PCNA-positive endothelial cell was determined by counting 
the entire testis section at 400x magnification. This was necessary since under normal 
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condition in adult testes, the number of proliferating endothelial cells is extremely low 
and random sampling was found to create large errors. At least five sections (taken 
every ten sections apart) were counted from each testis. The number of sections to be 
sampled was established based on a pilot analysis of the sampling variances which had 
to be less than 5%. 
In most studies, the number of proliferating endothelial cell was normalized 
against the tissue section area (number/mm^). However, in the developmental study 
and those experimental treatments where the ratio of tubular and intertubular area in 
the testis might change, the number of proliferating endothelial cells was also 
expressed as per unit intertubular area. 
2.8 Quantification ofblood vessel density 
Blood vessel density was quantified using a colour image analysis software 
(Video Pro 32, Leading Edge Pty. Ltd., Adelaide, Australia; installed on a 486-
33MHz PC computer) on serial sections obtained from ink-perfused testes. The 
sections were dewaxed and mounted in a permanent mountant ^DPX mountant, BDH, 
England) without staining. For each testis section, 20 randomly selected fields were 
captured at 100x magnification through a light microscope (Optiphot-2, Nikon, 
Japan) fitted with a video camera 0y/[odel TK-1280E, JVC, Japan) that input the 
signal into a PC computer (486-33MHz) and displayed the image (640 pixels wide by 
442 pixels high) on a computer monitor (15”，Sony Trinitron, Model CPD-15SF2, 
Japan). Using the threshold and measure function of the image analysis software, the 
ink-filled features indicating the blood vessels were discriminated against the 
unstained background and their numbers were counted OFigure 2.6). The actual area 
occupied by each displayed field on the computer monitor was determined using a 
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stage micrometer. From the total area occupied by the number of fields (total = 20) 
that were being sampled, the blood vessel density per unit section area was 
determined. 
2.9 Estimation of intertubular area in testis sections 
The percentage of the whole section area occupied by the intertubular area 
was estimated in those slides used for the quantification ofPCNA-positive endothelial 
cells. Using the colour image analysis software (Video Pro 32) and under 400x (for 
10-day old rats) or 200x (for other age groups and studies using adult animals) 
magnification, the boundaries between the tubular and intertubular area on the testis 
section were traced out on the computer monitor using a pointing device (i.e. PC 
mouse) and the editMraw function of the software. The intertubular regions were 
then discriminated using the edity^ fill function and their areas measured OFigure 2.7). 
For each testis section, 20 randomly selected fields were sampled. Care was taken to 
avoid those regions where there was an artifactual shrinkage/separation oftubular and 
intertubular tissues caused by the histological processing. From the percentage of 
total area occupied by intertubular tissue and the actual total area that was being 
sampled, the intertubular area present in each testis section was determined and used 
in the expression ofthe PCNA-positive endothelial cell count. 
2.10 Preparation of liposome-entrapped dichloromethylene diphosphonate 
(Cl2MDP-lp) 
The liposome-entrapped dichloromethylene diphosphonate (Cl2MDP) was 
prepared according to published methods (van Rooijen, 198¾ with slight 
modifications. 75 mg phosphatidylchoUne (Sigma) and 11 mg cholesterol (Sigma) 
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Figure 2.6 Use of the colour image analysis system to measure the density ofbIood 
vessels per unit area in testis sections, ln (A), the blood vessels filled with ink were 
seen as numerous black features against the pale background of the unstained section, 
ln (B), it is an identical field as shown in (A) with the ink-filled blood vessels being 
discriminated by the image analysis software and covered by red overlays. When 
setting the threshold in the above step, care was taken to avoid separate features 
beingjoined together or vice versa. 
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Figure 2.7 Use o f t h e colour image analysis system to determine the intertubular area 
in testis section. Testis sections of 10 days old rats (A & B) and adult rats (C & D) 
were shown to have their intertubular areas measured by a black overlay (B & D) 
generated by the image analysis software after the boundaries between tubular and 
intertubular areas were traced out manually using a point device. The percentage of 
the total testis section area occupied by intertubular tissues appears to decrease with 
increasing age of the rats. The red colour associated with the nuclei of some cells 
represents the positive immunostaining for PCNA. 
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were dissolved in 20 ml methanol/chloroform (1:1，v/v) QVlerck) in a 250 ml round 
bottom flask. The organic phase formed was removed at room temperature under a 
stream of nitrogen using a rotary evaporator O^abconco, Kansas, USA). The lipid 
fUm remaining was reconstituted in 10 ml chloroform which was similarly subjected to 
rotary evaporation at room temperature under a stream of nitrogen. At the end, the 
thin film that coated the bottom of the flask was dispersed either in 10 ml PBS 
containing 160 mg Cl2MDP for preparing Cl2MDP-lp, or in 10 ml PBS alone for 
preparing PBS-lp. After completely removing the lipid film, the suspension was left 
standing for 2 hours to determine whether it remained milky, indicating successful 
formation ofthe liposomes. The suspension was then subjected to 3 min sonication at 
room temperature in a waterbath sonicator QBranson, Shelton, Conn., USA). The 
liposomes were given another 2 hours to swell before they were spun down (100,000 
g for 30 min at 16°C) and washed twice in PBS. Finally, the liposomes were 
resuspended in 4 ml PBS and 150 i^l ofthis suspension were used for intratesticular 
injection. 
2.11 Radioimmunoassay of serum testosterone 
Sera collected were aliquoted and stored at below -20�C until being assayed 
for testosterone. For each animal, 100-300 i^l of serum were used and placed in a 
glass tube (150x16 mm. Coming, N,Y,, USA). Testosterone was extracted by 
vortexing each serum sample with 4 ml diethyl ether (Merck GR grade) for 1 min. 
The aqueous layer was allowed to settle for 30 min and then snap-frozen in liquid 
nitrogen. The ether layer was decanted into another glass tube (75x10 mm. Coming) 
and evaporated under a stream of air in a 40�C water bath for 15-20 min. The dried 
residue was reconstituted in assay buffer to the appropriate dilution and allowed to 
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stand at room temperature for 1 hour. Recovery of testosterone extraction was 
determined with the use of 100 |il working tracer diluted 1:3 in assay buffer. 
Following extraction, it was reconstituted in 300 ^1 assay buffer and duplicates of 100 
i^l were counted and compared with a working tracer of 1:9 dilution. In the present 
studies, no corrections were applied to the assays since the estimated percentages of 
recovery were all above 90%. 
The testosterone antibody was developed in-house by Drs. C.C. Wong & C.L. 
Au ^)epartment ofPhysiology, The Chinese University ofHong Kong). It was raised 
in rabbits against testosterone-3 -oxime-B SA conjugate (Sigma) and used at an initial 
dilution of 1:15,000. Under the assay conditions used, it showed 100% cross-
reactivity with dihydrotestosterone. The tracer [(l,2,6,7-rf)-testosterone, 
98.0Ci/mmol] was purchased from Amersham Buckinghamshire, England). An 
appropriate volume of the stock solution in toluene:ethanol (9:1) was evaporated to 
dryness and then reconstituted in assay buffer to 20,000 cpnV100 fiL t^ube. Anhydrous 
testosterone was purchased from Sigma Chemical Co. (St. Louis, MO, USA) and 
used as the standard covering a range of 25-1600 fmoU100 i^lAube. At the end of the 
assay, the separation of free from antibody bound testosterone was achieved by 
incubating each tube with 400 ^L'tube of dextran-coated charcoal [0.0625 g dextran 
T-70 ^>harmacia, Sweden) and 0.625 Norit-A charcoal (Serva, Texas, USA) in 100 
ml assay buffer] at 4°C for 30 min. The dextran-charcoal was subsequently separated 
by centrifugation at 1,000 g for 15 min. The supernatant which contained the 
antibody bound radioactivity was decanted into scintillation vials, equilibrated with the 
scintillation cocktail [0.4 g POPOP, 4 g POP in 700 ml toluene and 300 ml triton X-
100] for 1 hour and counted in a Uquid scintillination counter OBeckman LS-6000, 
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USA). The testosterone concentrations in the samples were computed from the 
standard curve using a programme prepared by the Radioimmunoassay Unit, 
Department ofMedicine, University ofHong Kong. 
The sensitivity of the testosterone radioimmunoassay was avearged to be 
20.6+7.5 fino^tube (mean±SD) (n=8). The intra-assay and inter-assay coefficient of 
variation were 6.7% and 12.7%，respectively (n=12). M serum samples from the 
one experiment were measured in the same essay. 
2.12 Statistical analyses 
Data were expressed as mean+SE. Statistical analyses were performed using a 
commercially available software package (SigmaStat for Windows Version 1.0, Jandel 
Scientific Software, San Rafael, CA, USA). Parametric tests were used wherever 
possible, unless the data failed in the normality test. For multiple comparisons among 
many groups, one-way analysis of variance (ANOVA) followed by Student-Newman-
Keuls test was used, and for multiple comparisons versus a single control group, one-
way ANOVA followed by Dunnett’ s test was used. For multiple comparisons among 
many groups using a non-parametric test, Kniskal-Wallis one-way ANOVA on ranks 
was used together with the Dunn's test. 
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3. Results 
3.1 hCG-induced increase in endothelial cell proliferation in adult rat testes 
3.1.1 Testicular histology 
The PCNA-positive endothelial ceUs were identified based on the specific 
nuclear staining for PCNA in those cells lining the waU ofblood vessels and with their 
nuclei protruding towards the lumen OFigure 3.1). Since the testes were fixed by 
vascular perfusion, the blood vessels could be easily distinguished from the lymphatic 
vessels by their dilated lumens which were clear of plasma and blood cells. 
In normal adult rat testes, there were very few PCNA-positive endothelial cells 
OFigure 3.1) and they were found in blood vessels throughout the entire testis section. 
After adult rats were given a single subcutaneous injection of 100 KJ hCG, there was 
a marked increase in the number of PCNA-positive endothelial cells suggesting a 
hCG-induced proliferation ofthis cell type ^"igure 3.1 and 3.2). Most of the increase 
in PCNA-positive endothelial cells was found lining the wall oflarge venules QFigure 
3.1) although it was also found elsewhere in capillaries and occasionally in arterioles. 
3.1.2 Changes in the number ofPCNA-positive endothelial cells 
In normal adult rat testes, the number ofPCNA-positive endothelial cells was 
relatively few. For a 5 ^m section taken from the equatorial region of the testis, it 
gave a mean value of about 20. However, 2 days after hCG stimulation, this number 
increased to a maximum ofabout 620/section. When comparisons were made based 
on the number of PCNA-positive endothelial cells per unit testis section area, an 
increase was evident 20 hours after hCG stimulation but it did not reach statistical 
significance ^>>0.05) until 24 hours post-hCG ^%ure 3.2). By 48 hours post-hCG, 
it reached a maximum value of about 30-fold above the control. After this, the 
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Figure 3.1 Representative proliferating cell nuclear antigen (PCNA) immunostaining 
in testes of adult rats that received a single subcutaneous injection of saline as in the 
control (A & B), or 100 IU hCG (C & D) 2 days prior to when the animals were 
killed for tissue collection, ln both animals, the spermatogonia located at the base of 
the seminiferous tubules were stained positive for PCNA. However within the 
interstitium, PCNA-positive endothelial cells (indicated by arrows) were a lot more 
abundant in the testes of the hCG-injected animals than the control. Most of the 
PCNA-positive endothelial cells were found lining the wall of large venules or 
capillaries, ln the control animals, PCNA-positive endothelial cells were a lot less 
abundant. 
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Figure 3.2 Changes in the number of PCNA-positive endothelial cells ^)er unit 
section area) in testes of adult rats at various times ranging from 12 hours to 7 days 
after receiving a single subcutaneous injection of 100 JU hCG. 
Data represent mean+SE of 5-6 animals per group. 
*P<0.05, compared with saline-injected control (CTR) using one-way ANOVA 
followed by Dunnett's test. 
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number of PCNA-positive endothelial cells graduaUy declined to reach a value 
insignificantly different from the control at 5 days post-hCG, and almost completely 
returned to the control value after 7 days OFigure 3.2). 
3.1.3 Changes in blood vessel density 
Associated with the hCG-induced increase in the number of PCNA-positive 
endothelial cells, the blood vessel density per unit testis section area exhibited a small 
and yet significant (P<0.05) increase at 3 and 5 days post-hCG O^igure 3.3). By 7 
days after the hCG injection, it returned to a value insignificantly different from that of 
the control. The changes of this parameter including the first significant rise, the 
attainment of the maximum increase and the recovery back to normal values, all 
appeared to precede a similar pattem of changes in PCNA-positive endothelial cell 
number by about 1-2 days. 
3.1.4 Changes in testis weight and serum testosterone concentration 
The testis weight ofthe hCG-injected rats was significantly (P<0.05) elevated 
between 16 and 24 hours after treatment (Table 3.1). By 2 days post-hCG, it had 
already recovered back to a value insignificantly different from that of the control. 
In line with previous reports, a single injection of hCG induced a biphasic 
serum testosterone response in adult rats OFigure 3.4). Jn the present study, the first 
peak of serum testosterone was noted at around 16-20 hours post-hCG. This was 
followed by a nadir at 2 days before a second peak appeared at 5 days post-hCG. 
When the number ofPCNA-positive endotheUal cells per unit section area was 
correlated with the serum testosterone concentration based on their average values 
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Figure 3.3 Changes in the blood vessel.density in the testes of adult rats at various 
times after receiving a single subcutaneous injection of 100 HJ hCG. 
Data represent mean+SE with the number of animals given at the base of each bar. 
*P<0.05, compared with saline-injected control (CTR) using one-way ANOVA 
followed by Dunnett's test. 
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I ‘ Paired Testis Weight 
TimeaflerhCG toam) «_彻.ofAnimals 
Control 3.416土0.080 ^  
U h 3.514土0.112 6  
16h 3.853 士0.064* ^  
^ 4.082土0.133* 6  
r ^ 3.917土0.096* 6  
2days 3.632士0.106 ^  
3 days 3.416土�.176 ^  
5days 3.474 土 0.068 ^  
7days 3.249士0.129 ^   
_ = _ = = — L = ~ — = — — ~ ® = = ~ ~ " " " " " " " ^ " ^ 
Table 3.1 Changes in paired testis weight of adult rats at different times after 
receiving a single subcutaneous injection of 100 EJ hCG. 
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Figure 3.4 A biphasic change in serum testosterone concentration in adult rats after 
receiving a single subcutaneous injection of 100 RJ hCG. 
Data represent mean+SE of 5-6 animals per group. 
*P<0.05, compared with saline-injected control (CTR) using one-way ANOVA 
followed by Durmett's test. 
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value) of-0.132 was obtained. Subsequent statistical analysis indicated that there was 
no significant correlation (n=9, P>0.80) between these two parameters (FigarQ 3.5). 
3.2 Effect of Leydig cell depletion by ethane dimethane sulphonate O^DS) on 
hCG-induced endothelial cell proliferation in adult rat testes 
3.2.1 Testicular histology 
In adult rats, injection ofEDS resulted in a marked reduction in the number of 
testicular interstitial cells within 4 to 5 days after treatment OFigure 3.6). This was 
indicated by fewer numbers of cells and enlarged spaces in the testicular interstitium. 
Accompanying the loss of interstitial cells, the endothelium lining the testicular 
vasculature failed to respond to hCG stimulation with an increased number of cells 
expressing PCNA immunoreactivity ^"igure 3.6). 
3.2.2 Changes in the number ofPCNA-positive endothelial cells 
Under basal condition (without hCG stimulation), injection of EDS or the 
vehicle (i.e. DMSO) alone had no significant effect on the number ofPCNA-positive 
endothelial cells in adult rat testes when compared with the control OFigure 3.7). 
However, prior EDS treatment completely abolished the hCG-induced increase in 
PCNA-positive endothelial cell number that was present in normal testes at 1 and 2 
days post-hCG OFigure 3.7). The density of PCNA-positive endothelial cells in the 
testes ofEDS-treated animals injected with hCG was not significantly different from 
that found under basal condition in normal, EDS-treated or DMSO-injected rats. In 
EDS-treated animals, the failure ofPCNA-positive endothelial cell number to increase 
in response to hCG did not appear to be related to the vehicle injection since DMSO 
had no significant 0P>O.O5) effect on the basal or the hCG-induced increase in the 
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Figure 3.5 Correlation of the average PCNA-positive endothelial cell number/unit 
testis section area with the corresponding average serum testosterone levels in adult 
rats at different times after receiving a single subcutaneous injection of 100 RJ hCG. 
(n=9,r = -0.132, P>0.80). 
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Figure 3.6 Representative PCNA immunostaining in testes of adult rats that received 
ethane dimethane sulphonate (EDS) 3 days before being injected with a single dose of 
saline (A & B) or 100 IU hCG (C & D) and studied 2 days post-hCG. Note that in 
both (A & B) and (C & D), there were very few interstitial cells after EDS treatment. 
The hCG-induced increase in the number ofPCNA-positive endothelial cells as shown 
in Figure 3.1 could no longer be observed in the testes of EDS-treated rats (shown in 
C & D ) . 
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Figure 3.7 Effect of Leydig cell depletion on hCG-induced endothelial cell 
proliferation. Number of PCNA-positive endothelial ceUs (per unit section area) 
was determined in the testes of adult rats that received i.p. injection of ethane 
dimethane sulphonate OEDS) or the vehicle - dimethyl sulphoxide ^)MSO) 3 days 
prior to being given a single subcutaneous injection of hCG and studied at 1 day 
and 2 days post-hCG. 
Data represent mean+SE with the number of animals given in parentheses. 
*P<0.05, compared with saline-injected control (CTR) and 
fP<0.05，compared with the corresponding "EDS-treated + hCG-injected" group, 
using one-way ANOVA followed by Student-Newman-Keuls test. 
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number of PCNA-positive endothelial cells when compared with the corresponding 
groups ofnormal rats injected with saline (control) or hCG (1 day hCG) alone. 
3.2.3 Changes in serum testosterone concentration and testis weight 
As expected, prior treatment of adult rats with EDS to destroy the Leydig 
cells resulted in a marked decrease in serum testosterone to very low levels that were 
approaching the detection limit of the radioimmunoassay OFigure 3.8). Jn these 
animals, their serum testosterone levels failed to show any significant changes even at 
24 and 48 hours after receiving a subcutaneous injection of 100 JU hCG. When only 
the EDS-treated animals (with or without receiving hCG injection) were compared 
with either the saline-injected control or the vehicle ODMSO)-injected group (using 
one-way ANOVA followed by Student-Newman-Keuls test), their serum testosterone 
levels were shown to be significantly lower (P<0.05). However such statistical 
differences were loss when other treatment groups from the same experiment were 
included in the statistical analysis (Figure 3.8). In line with earlier findings, a 
significant increase in serum testosterone was observed at 1 and 2 days post-hCG in 
those animals with an intact population ofLeydig cells OFigure 3.8). Prior injection of 
DMSO (i.p.) in these animals had no effect 0P>O.O5), if not a stimulatory one, on the 
serum testosterone response to hCG. 
In EDS-treated rats, their testes weight did not differ significantly in 
comparison with the control when examined at 4 to 5 days after treatment. However 
unlike the group of normal or DMSO-injected animals, their testes weight failed to 
exhibit any significant changes or sign of an increase, 24 hours after receiving a 
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Figure 3.8 Effect of ethane dimethane sulphonate ^DS) or the vehicle ^DMSO) 
treatment on the serum testosterone concentrations in adult rats that were subsequently 
given a single subcutaneous injection of 100 RJ hCG (or saline) and studied at 1 and 2 
days post-HCG. 
Data represent mean+SE with the number of animals given in parentheses. 
*P<0.05, compared with saline-injected control (CTR) using one-way ANOVA followed 
by Dunnett's test. 
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« 
‘ “ P a i r e d TestisWeight“ j 
Treatment (gram) No. ofAnimaIs 
Control 3.416士0.080 ^   ： 
DMSO 3.525 土0.130 5 
5 ^ 3.475士0.100 7 
DMSO + 1 day hCG 3.752 土 0.066卞 ^ 
1 day hCG 3.917士0.096*卞 6 
EDS + 1 day hCG 3.270士0.102 7 
2 day hCG 3.632士0.106 ^ 
EDS + 2 day hCG 3.473 土 0.091 6  
Table 3 2 Effect of pre-treating adult rats 3 days earlier with ethane dimethane 
sulphonate or the vehicle ODMSO) alone followed a single subcutaneously injection of 
100 nJ hCG (or saline) on the paired testis weight measured at 1 and 2 days post-
hCG. 
Data represent mean±SE. *p<0.05, compared with saline-injected control using one-way ANOVA followed by 
Dunnett's test, and . tP<0.05, compared with "EDS + 1 day hCG" treatment group using one-way 
ANOVA followed by Student-Newman-Keuls test. 
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3.3 Effect ofLeydig cell suppression by testosterone-filled subcutaneous silastic 
implants on hCG-induced endothelial cell proliferation in adult rat testes 
3.3.1 Changes in serum testosterone concentration, testis weight, and testicular 
intertubular area 
The two doses oftestosterone implant were chosen such that the 3 cm implant 
would achieve normal physiological levels of serum testosterone but fail to provide 
adequate hormonal support for normal spermatogenesis, and the 25 cm implant would 
maintain near normal levels of spermatogenesis with a supraphysiological 
concentration of serum testosterone. These were well illustrated by the present 
results on the serum testosterone and the testis weight. 
Serum testosterone levels in the 3 cm-implant group were almost identical to 
those ofthe age-matched control, and no statistical differences could be demonstrated 
between the two groups (Table 3.3). In animals bearing the 25 cm implant, their 
serum testosterone levels were significant higher 0P<O.O5) and gave a mean value of 
about 5-6 times that ofthe age-matched control or the 3 cm-implant group. Animals 
receiving exogenous testosterone implants (3 cm or 25 cm) showed a reduced serum 
testosterone response to hCG stimulation (Table 3.3). In the age-matched control not 
bearing any implants, serum testosterone was significantly elevated 0P<O.O5) above 
basal by about 3-fold at 48 hours after receiving a single s.c. injection of 100 RJ hCG. 
In the 3 cm-implant group, hCG did not produce a significant rise in serum 
testosterone to levels above the basal. In the 25 cm-implant group, serum 
testosterone increased significantly (P<0.05) in response to hCG stimulation, but the 
increment was less than that observed in the age-matched control and represented 
only a 28% rise above the basal value found in the same treatment group (Table 3.3). 
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Control Treatment Groups 
Testosterone 
Implant No Implant L ^ ^ ^  
Subcutaneous , — ” . ^ ^ T n j - t t - c<aw h rG saline hCG salme h C G _ 
PairedTestis 3.473 3.632 2.151 2.327 3.098 3.435 
Weight 士 士 土 士 土 _=^ 1丄 
(gram) 0.092 0.106 0.146* 0.089* 0.119* 0.081卞  
Percentage 
testis section ^^ ^^ 15 19 i6.80 25.31 15.48 17.40 
area occupied 士 士 士 士 士 士 
by 0 91 0.55 1.26 2.28*，卞 1.16 1.97 intertubular tissues (%) 
Serum ^ O i 7 6士 2.1士 2.9士 11.5士 14.7土 
Testosterone ^ ^ 11卞 0.2 0.4* 0.6* l . l* , t 
(ngyW)  
No. of 5 5 6 6 6 6 
Animals  
^ 
Table 3 3 Effect of chronic Leydig cell suppression followed by acute hCG 
stimulation on the testis weight, percentage testis section area occupied by 
intertubular tissues, and serum testosterone concentration in adult rats. Chronic 
Leydig cell suppression was achieved by an 8-week treatment with either a low dose 
(3 cm) or a high dose (25 cm) oftestosterone-filled subcutaneous implants. At the 
end o f8 weeks, the animals were given a single subcutaneous injection ofhCG (100 
nJ) and studied 2 days post hCG. 
Data represent mean+SE. • 
*P<0 05 compared with the corresponding saline- or hCG4njected group bearmg no 
implants�and t P<0.05, compared with the corresponding saline-injected group 
receiving the same length ofimplant or no implant, using one-way ANOVA followed 
by Student-Newman-Keuls test. 
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In animals bearing the testosterone implants, the fall in testis weight mainly 
represented the loss ofspermatogenic activity in the testes. In both 3 cm- and 25 cm-
implant groups, the testis weight decreased significantly 0P<O.O5), and reached 61.9% 
and 89.2% of the value found in the age-matched control, respectively (Table 3.3). 
Following the injection ofhCG, there was a tendency for the testis weight to increase 
in the normal as well as the testosterone-implanted groups. However, only those 
animals bearing the 25 cm implant responded with a significant increase (P<0.05) in 
testis weight above the basal found within the same treatment group or to a value 
which was insignificantly different from that in the age-matched control exposed to 
the same treatment (Table 3.3). 
Since the testosterone implants affected the spermatogenic activity in adult rat 
testes, the size of the seminiferous tubules might decrease and so would be the area 
occupied by the tubular tissue. This would in tum affect the cross-sectional area of 
the testis upon which the quantification ofPCNA-positive endothelial cell number was 
based. In an attempt to correct for this, the percentage of testis section area 
occupied by the intertubular tissue was determined in this experiment for the control 
and treatment groups. The intertubular area represents where the blood vessels are 
situated and it should be less affected by changes in the levels of spermatogenic 
activity within the seminiferous tubules. This might provide a better basis for 
expressing the surface density ofPCNA-positive endothelial cells in testis sections. 
Results indicated that under basal condition, there were no statistical 
differences among the age-matched control and the treatment groups in terms of the 
percentage testis section area occupied by the intertubular tissue (Table 3.3). 
Nevertheless the values from these three groups of animals could be ranked in the 
ascending order of control < 25 cm-implant group < 3 cm-implant group. This might 
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follow the expected trend of decreasing spermatogenic activity (or decreased 
seminiferous tubular size) in these animals. Following the exposure to hCG, the 
intertubular area showed a tendency to increase. In the 3 cm-implant group, it 
reached a significantly higher value when compared with the basal condition in the 
same treatment group or with the age-matched control exposed to the same dose of 
hCG(Table3.3). 
3.3.2 Changes in the number ofPCNA-positive endothelial cells 
Chronic Leydig cell suppression by exogenous testosterone released from 
subcutaneous silastic implants did not significantly affect the area density ofPCNA-
positive endothelial cells in the testes under basal condition OFigure 3.9). This holds 
true irrespectively ofwhether the cell density was expressed as per unit section area 
P^igure 3.9(A)] or as per unit intertubular area ^ g u r e 3.9(B)]. Similarly, Leydig cell 
suppression did not appear to have any negative effect on the hCG-induced increase in 
the number ofPCNA-positive endothelial cells in the testis. Although a low dose (3 
cm) and a high dose (25 cm) oftestosterone implants were used to achieve Leydig 
cell suppression, the results between the two treatment groups were not significantly 
different except when the number ofPCNA-positive endothelial cells was expressed 
as per unit section area. Li the 3 cm-implant group, this method of expression gave a 
significant higher value than the age-matched control and the 25 cm-implant group 
when compared after hCG treatment P^igure 3.9 (A)]. However such differences 
disappeared when the density ofPCNA-positive cells was based on the area occupied 
by the intertubular tissue P^igure 3.9 (A)]. 
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Figure 3.9 Effect of Leydig cell suppression on hCG-induced endothelial cell 
proliferation in adult rat testes. The number of PCNA-positive endothelial cells 
expressed either as per unit section area (A) or as per unit intertubular area fB), was 
determined in the testes of adult rats bearing 3 cm or 25 cm testosterone-filled 
implants for 8 weeks prior to being given a single subcutaneous injection of 100 JU 
hCG (or saline) and studied 2 days post-injection. Animals bearing no implants served 
as the control. 
Data represent mean±SE with the number of animals indicated in parentheses. 
*P<0.05, compared with the corresponding saline-injected group (receiving no hCG), 
and tP<0.05, compared with the "hCG-injected 3 cm implant" group, using one-way 
ANOVA followed by Student-Newman-Keuls test. 
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3.3.3 Changes in the level of vascular endothelial growth factor (VEGF) 
immunoreactivity in the testis 
In view of the earlier findings demonstrating a requirement for Leydig cells to 
mediate the hCG-induced increase in the number ofPCNA-positive endothelial cells, 
the following study was carried out to determine how the suppression of Leydig cell 
function would affect the expression of a potent angiogenic factor - vascular 
endothelial growth factor, in the testis. In the control animals, VEGF immunostaining 
was localized mainly in the intertubular area within the cytoplasm of the interstitial 
cells [Figure 3.10 A & B], although Sertoli cells and vascular smooth muscle cells 
also contained some immunoreactivity. In animals bearing the testosterone implants, 
the interstitial cell population regressed considerably, and most of the VEGF 
immunoreactivity was lost from the intertubular area except the one present in 
vascular smooth muscle cells [Figure 3.10 C-F]. In comparison, the expression of 
VEGF in Sertoli cells had apparently increased in those animals bearing the 
testosterone implants. 
3.4 Effect of testicular macrophage activation by polystyrene latex beads on hCG-
induced endothelial cell proliferation in adult rat testes 
3.4.1 Testicular histology 
Intratesticular injection of polystyrene latex beads resulted in their 
accumulation in the cytoplasm of the testicular macrophages. As a result, the nuclei 
of these cells were pushed to one side. This phenomenon was recorded at 4-5 days 
after treatment [Figure 3.11(A)]. 
When the latex beads-induced testicular macrophage activation was combined 
with the stimulation by hCG, a marked increase in endothelial cell proliferation was 
60 
A , ‘ 髮 . ’ 、 、 . ^ m < ^ m B ^ ^ v : ‘ 一 T 7 ^ 
•?V- •'' ; ' J ^ � : } � i i ^ . Y • ? 4 , S ‘ , •% 
^ ’ 舞 鲁 取 、 ， 参 
. , T , i _ , 森 _ _ . : : 
条 ， ‘ 參 感 该 > ^ , : , : , 、 屬 . : ; ： 
“ ” ; # ! f e / “ � / . ) f e " . : . . . f % “ . ^ / r . - ： 、 "- /^^,. 
i ^ - > - 'N -^ - i^ -'' ';' -V W : v ; •%/ . . , 1立、 
f i ^ 、•、 ' ’。參― ^ r - - ^ ‘•叔‘ 
i f ^ " ^ ^ f . . 掌 “ ’ 齊 6 、 ^ ^ ^ : . . 中 : 」 , ^ ^ 
: u T > % : , , . # > • ^4 . : ¾ ¾ ¾ ^ ^ ^ , ; ¾ ^ . 
^ ¾ ¾ ¾ % ¾ ' : : : f ^ f t t ^ : . . 
_ _ _ , ¥ t ^ ^ | i : ‘ : . •^^mm^^m 
• ^ ^ • : . • . • ！ ® ^ : . : : v � : � � > ^ I ' : _ ^ ^ 
i ^ J% ^ s r - v 4 c ^ ' • V； 广-);袋.,'...％;於〜、•. % ^ ‘ ^ ' - ¾ - ¾ ' . - ¾ . ¾ ^ 
f j < ^ r ^ ^ ^ " ^ ^ ^ ^ ^ _ 、 : 二 喻 ； / ‘、 5 ^ - - . ^ l ./：1^^ . . . . . . � _ — •-. ^ - Jli?- ^^ .：^ . . Figure 3.10 Immunohistochemical staining for vascular endothelial growth factor (VEGF) in the testes of nor al adult rats (A & B) nd adult r ts that receivedsubcutaneous testosterone-filled silastic implants of 3 cm (C & D) or 25 cm (E & F)in length for 8 week , ln nor al testes (A & B), most of the specific staining fVEGF was found within the y op s  of inter titial cells. In anim ls be ringtestos ero e implan s f ithe  3 cm or 25 cm in length, ma y of the in erstitial cellshad gress d and th  VEGF i mun was found main in id the Ser oli withi  emi if rous tubu s.
61 
\ . ， ^ : m ^ 
: 么 . . , . . : : : 〜 為 _ 
•. ^ r ^ 7 *�4ij^> I 
�洛 . • ' • , - ‘ 、"呢 ..;.、 塵.，、.,：：>^ 
. 、、也',少.’ ^ ^ % 、、“. 
/ ， i A - 9 ^ ^ ^ •.‘ ；•： 
� ^ ‘ ‘ f ‘ m ^ ^-^， 
。 靠 : > ^ ‘ 纖 
: : , : � � � , f ^ _ , K 
^ - i # ^ e S . ^ i V t ^ 
# ^ : _ 聊 讓 ¥^^ 
: I ^ . . : . ; . ' : : . ^ ^ ^ J ^ 
Figure 3.11 Testis sections (stained with haematoxylin) from adult rats that received 
intratesticular injection of polystyrene latex beads 3 days prior to being given a single 
subcutaneous injection of 100 lU hCG and studied 2 days post-hCG. (A) Under high 
magnification (1000x), testicular macrophages (indicated by arrows) were seen 
heavily laden with polystyrene latex beads and their nuclei were displaced to one side 
of the cells. (B) Macrophage activation combined with hCG stimulation resulted in a 
marked stimulation of endothelial cell proliferation. The arrow points to an endothelial 
cell undergoing mitotic division. 
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observed. In testis sections, the number of endothelial cells exhibiting the mitotic 
figure became a lot more abundant [Figure 3.11(B)], and this was also accompanied 
by a large increase in the number of PCNA-positive endothelial cells (data presented 
below). 
3.4.2 Changes in the number ofPCNA-positive endothelial cells 
In the study of testicular macrophage activation, latex beads were injected 
unilaterally into the right testis while the contralateral testis was injected with sterile 
saline and used as the sham-operated control. Intratesticular injection of saline alone 
induced a significant increase (P<0.05) in the number of PCNA-positive endothelial 
cells, and the effect appeared to subside with the duration after treatment (Figure 
3.12). Thus in the saline-injected testes not exposed to hCG stimulation, the density 
ofPCNA positive endothelial cells increased above the basal value of 0.22 celllmm2 in 
normal control testes to 3.28 ceUs/mm2 4 days after intratesticular injection, before it 
fell to 2.74 cells/mm2 at 5 days post-injection (Figure 3.12). Such increases were 
similarly observed after the intratesticular injection of latex beads alone in the absence 
of hCG stimulation, and the effect also appeared to decrease with time after treatment 
with 5.54 cells/mm2 and 2.41 cells/mm2 at 4 and 5 days post-injection, respectively. 
Intratesticular inj ection of latex beads induced a significantly (P<O. 05) larger increase 
in the density ofPCNA-positive endothelial cells than saline injection when examined 
at 4 days after treatment [Figure 3. 12(A)], but the difference disappeared on the 5th 
day [Figure 3 .12(B)]. 
When hCG-induced endothelial cell proliferation in adult rat testes was 
examined after testicular macrophage activation by the injection of latex beads, a 
significant interaction between the two treatments was observed. At 2 days post-
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Figure 3 12 Effect oftesticular macrophage activation by latex beads on hCG-induced 
endothelial cell proliferation in adult rat testes. Number ofPCNA-positive endothelial 
cells 0)er unit section area) was determined in the testes ofadult rats thatreceivedan 
intratesticular injection ofpolystyrene latex beads (2% in 150 ^1 sten e salme) mto the 
right testes and sterile saline into the left testes (sham-operated control) 3 days pnor to 
bdng given a single subcutaneous injection of 100 JXJ hCG and studied at 1 day (A) 
and 2 days � post-hCG. 
Data represent mean±SE with the number ofanimals given in parentheses. 
*p<0.05, using one-way ANOVA followed by Student-Newman-Keuls test. 
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hCG, the density of PCNA-positive endothelial ceUs increased from 8.69±0.87 
cells/mm^ (mean±SE) for hCG stimulation alone and 2.41土0.45 c e l l s W for latex 
beads4nduced macrophage activation alone to a value of20.3±3.75 c e l l s W for the 
combined treatment of the two Pgure 3.12(B)]. Similar interaction with an even 
greater increase above the individual effects was noted 1 day after the injection of 
hCG Figure 3 . 1 2 � ] . Since the combined effect of the two treatments was 
approaching twice the sum oftheir individual effects，the data strongly suggested a 
synergistic interaction between hCG stimulation and macrophage activation in 
inducing endothelial cell proliferation in adult rat testes. Little or no synergism 
appeared to be present when hCG stimulation was combined with the sham-operation 
ofinjecting saline intratesticularly. At 2 days post-hCG, the density ofPCNA-positive 
endothelial cells in saline-injected and hCG-stimulated testes was 11.17士1.03 
c e l l s W , which was roughly the sum ofthe individual effect due to hCG stimulation 
(8.69db0.87 c e l l s W ) and intratesticular saline injection (2.74土0.65 c e l l s W ) alone 
PFigure3.12(B)]. 
3.4.3 Changes in testis weight and serum testosterone concentration 
Intratesticular injection oflatex beads or saUne did not result in any significant 
changes in testis weights, although the values at day 4 post-injection (1.795±0.076 g 
for saline-injected and 1.975±0.170 g for latex bead-injected; mean±SE) were slightly 
higher 0>>0.05) than those recorded at day 5 (1.796土0.042 g for saHne-injected and 
1.697i0.079 g for latex bead-injected) (Table 3.4). The intratesticular injection also 
appeared to produce larger variations in testis weight and thus mask the acute effect 
of hCG in producing a significant increase in testis weight at 1 day post-hCG. Li 
animals not receiving any intratesticular injection, a significant increase in testis 
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Subcutaneous IntratesticuIar Unpaired Testis Tp<f=IT^nA 
Ejection Ejection Weight(gram) 二 ： 
saline (control) - 1.708士0.040 5.0士1.1 
(n=5) (n=5) 
1 day hCG - 1.958士0.048* 10 .0 i l .8* 
(n=6) (n-5) 
saline 1.795±0.076 
1 day saline … 5 ) 8.3 士 1.9 
latex beads 1.975 士 0.170 (^=5) 
M  
saline 1.855±0.093 
1 day hCG ( �” 14.1 ± 2.2* 
latex beads 2.015 士 0.232 ( n = � 
(n=5)  
2 days hCG - 1.816士0.053 5.8士0.8 
(n=5) (n=5) 
saline 1.796士0.042 
2 days saline ( � $) 4.6 士 0.7 
latexbeads 1.697士0.079 (^=5) 
(n=5)  
saline 1.652士0.057 
2 days hCG ( �” 5.2±0.6 
latex beads 1.561 土 0.078 ("=$) 
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Table 3.4 Effect of testicular macrophage activation followed by acute hCG 
stimulation on the testis weight and serum testosterone concentration in adult rats. 
Testicular macrophage activation was induced unilaterally by injecting polptyrene 
latex beads into the right testis. Sterile saline was injected into the left testis which 
served as the sham-operated control. Three days later, 100 JU hCG was injected 
subcutaneously and the animals were studied at 1 day and 2 days post-hCG. 
Data represent mean±SE. No statistical difference in the testis weight was observed. 
*P<0.05, compared with the control using one-way ANOVA followed by Dunnett's 
test. 
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weight was recorded at 1 day post-hCG (1.958土0.048 g for hCG-injected versus 
1.708i0.040 g for the control), and in animals with saline- (L855±0.093 g) and latex 
beads-injected (2.015士0.232 g) testes, the increases in weight were not statistically 
significant (Table 3.4). It was also noted that at 2 days post-hCG, those animals that 
had previously been given intratesticular injections of saline and latex beads appeared 
to have a lower testis weight when compared with the control, although their 
differences were not statistically significant. 
In the treatment groups, intratesticular injection oflatex beads and saline (into 
the right and left testis respectively) did not produce any significant systemic 
endocrine changes in terms of serum testosterone levels when examined at 4-5 days 
after treatment. Their serum testosterone levels (8.3土1.9 ng/ml and 4.6±0.7 ng/ml, 
respectively) did not differ significantly from those present in the normal control 
(5.0iLl ng/ml) (Table 3.4). Subcutaneous injection of 100 EJ hCG in these animals 
produced a significant QP<0.05) rise in serum testosterone when examined at 24 hours 
(14.1i2.2 ng/ml) but not 48 hours (5.2db0.6 ngAnl) post-hCG. Their serum 
testosterone responses did not differ significantly from those determined at the 
corresponding times of24 (10.0il.8 ngAd) and 48 hours (5.8i0.8 ng/ml) post-hCG 
in normal rats (without receiving any intratesticular injection). 
3.5 EfFect of testicular macrophage depletion by liposome-entrapped Cl2MDP 
treatment on hCG-induced endothelial cell proUferation in adult rat testes 
3.5.1 Testicular histology 
Intratesticular injection of CbMDP-lp resulted in the depletion of testicular 
macrophages which progressed from the centre to the surface of the testis OFigure 
3.13). hi the present study, these animals were used 14 days p0st-Cl2MDP-lp 
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injection. This duration of treatment had previously been shown to produce the 
maximum decrease in the number of testicular macrophages to reach about 14% of 
the normal control values (Bergh, Damber & van Rooijen, 1993). 
In normal adult rats, subcutaneous injection of 100 RJ hCG resulted in a 
marked infiltration of polymorphonuclear leucocytes OPMN) into the testes, however 
the changes would have completely subsided by 32 hours post-hCG. In animals that 
received intratesticular injection of Cl2MDP-lp to deplete the testicular macrophages, 
the infiltration of PMN could still be observed at 48 hours post-hCG when many 
PMN were seen adhering to the wall of blood vessels and lying within the testicular 
interstitium ^Figure 3.14). 
3.5.2 Changes in the number ofPCNA-positive endothelial cells 
Bilateral intratesticular injection of Cl2MDP-lp to deplete the testicular 
macrophages did not result in any significant changes in the density ofPCNA-positive 
endothelial cells in adult rat testes when examined under the basal state (in the 
absence ofhCG stimulation). The comparisons were made 16 days after the injection 
and they showed no significant differences among the Cl2MDP-lp-injected animals, 
the sham-operated (receiving intratesticular injection of PBS-lp) and the normal 
(receiving no injection) control groups (Figure 3.15). However, Cl2MDP-lp treatment 
(given 14 days earlier) significantly potentiated the effect of hCG in inducing an 
increase in the number of PCNA-positive endothelial cells in adult rat testes when 
examined at 2 days post-hCG. The density ofPCNA positive endothelial ceUs in the 
Cl2MDP-lp-injected testes exposed to hCG (13.16±2.25 cells/mm^; mean±SE) was 
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Figure 3.13 Intratesticular injection of CbMDP-lp caused the depletion of 
macrophages to progress from the centre to the surface of the testis. In (A) (without 
counterstaining), it shows the junction between two regions of the testis with and 
without trypan blue-labelled testicular macrophages. In (B), it shows a testis two 
weeks after Cl2MDP-lp treatment when the testicular macrophages (indicated by 
arrows) were mostly confined to the region immediately beneath the testicular 
capsule. 
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Figure 3.14 Testis sections (stained with haematoxylin) from adult rats that received 
intratesticular injection of CbMDP-lp 2 weeks prior to being given a single 
subcutaneous injection of 100 IU hCG and studied 2 days post hCG. An 
inflammation-like reaction of polymorphonuclear (PMN) leukocyte (indicated by 
arrows) infiltration was observed similar to the early response of normal testes to the 
same dose of hCG within 4-16 hours post-hCG. Some PMN leukocytes were found 
adhering to the endothelial lining ofblood vessels while others had infiltrated into the testicular interstitium. 
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Figure 3.15 Effect of testicular macrophage depletion by CkMDP-lp treatment on 
hCG-induced endothelial cell proliferation in adult rat testes. Number of PCNA-
positive endothelial cells (per unit section area) was determined in the testes of adult 
rats that received intratesticular injection of Cl2MDP-lp ( � 6 mg in 150 i^l PBS) or 
PBS-lp (in the sham-operated control) 14 days prior to being given a single 
subcutaneous injection of 100 RJ hCG (or saline) and studied 2 days post-hCG. 
Data represent mean+SE with the number of animals given in parentheses. 
*P<0.05, using one-way ANOVA followed by Student-Newman-Keuls test. 
71 
normal (8.69±0.87 cells/mm^) testes stimulated by the same dose of hCG (Figure 
3.15). 
3.5.3 Changes in testis weight and serum testosterone 
Intratesticular injection of CbMDP-lp or PBS-lp did not produce any 
significant alteration in testis weight when compared with the age-matched control at 
16 days after the treatment (Table 3.5). In these animals, their testis weight remained 
insignificantly affected even after they had received a subcutaneous injection of 100 
n j hCG 2 days earlier, and compared against the corresponding treatment groups not 
exposed to hCG (Table 3.5). Similar findings were recorded when comparing the 
testis weight of normal rats (not receiving any intratesticular injection) with and 
without receiving the same dose ofhCG. 
Intratesticular injection of Cl2MDP-lp or PBS-lp resulted in a fall in serum 
testosterone levels when comparisons were made against the normal control matched 
for age (Table 3.5). Between the Cl2MDP-lp-injected group (1.0±0.3 ng/ml; 
mean±SE) and the control (5.0±1.1 ng/ml), the difference was statistical significant 
^><0.05). When the Cl2MDP-lp and PBS-lp injected groups were given a 
subcutaneous injection of 100 RJ hCG, their serum testosterone levels (7.7±0.7 ng/ml 
and 7.8il.4 ng/ml, respectively) became significantly elevated above the basal after 2 
days and did not differ significantly from the values determined in the group of normal 
rats (5.8i0.8 ng/ml) similarly treated with the same dose ofhCG. 
3.6 Endothelial cell proliferation in rat testes during postnatal development 
3.6.1 Changes in the number ofPCNA-positive endothelial cells 
72 
i^ M^ ^^ ^^MM^ -^p-!^ ^^ggss!^ g^g^ ^^gss^ ^^gs^ ^^ ^^ssBssBsssssisssssssssss^ s^ ^^ ^^ ^^ ?^? Tr*^*^r*^*7?^^^*^ *^^*^*^*^*^*^*^*^*^*^t?^t7^r^ r^rr!r7^rrr^T?r^rrrrrrrrrr!]^!^?|!^!|t|?!^]^l^l^|i^^^]^l^l^ !^^]^[^l^ !^^^^!^]^!^l^i^|^!^!^!^!^!^  
Control Treatment Groups  
Intratesticular • PBS-lp CUMDP-Ip 
Injection 
Subcutaneous 名血已 hCG saline faCG saline hCG fcjectJon  
Paired Testis 3.416 3.632 3.653 3.801 3.806 3.646 
Weight 士0.080 土0.106 士0.104 士0.078 士0.050 士0.114 
(gram) (n=5) (n=6) (n=5) (n=5) (n=5) (n=5) 
Semm 5 0士1.1 5.8土0.8 2.4士0.7 7.8土 1.0士0.3 7.7士 
Testosterone (打=5) (n=5) (n=5) 1.4* (n=5) 0.9* 
(ng/ml) (n=5) (n=5) 
L _ = J  
Table 3.5 Effect of testicular macrophage depletion followed by acute hCG 
stimulation on the testis weight and serum testosterone concentration in adult rats. 
Testicular macrophage was depleted by CbMDP-lp treatment given 14 days before 
100 n j hCG was injected subcutaneously, and the animals were studied at 2 days 
post-hCG. 
Data represent mean+SE. 
*P<0.05, compared with the corresponding saline-injected group using one-way 
ANOVA followed by Student-Newman-Keuls test. 
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When the number ofPCNA-positive endothelial cells was expressed over per 
unit section area, the maximum value (6.4±1.6/mm^; mean±SE) was found in 10-day 
old rats pFigure 3.16(A)]. Between 10 and 20-day old rats, this value dropped by 
about half (to 3.3±0.08/mm^) before it continued to decline gradually to the lowest 
value found in 90-day old rats (0.27±0.06/mm^). In view of the fact that the above 
expression could be influenced by the initiation of spermatogenesis in the seminiferous 
tubules leading to an enlargement of the tubular compartment and hence its 
contribution towards the total testis section area, comparisons were also made based 
upon the number ofPCNA-positive endothelial cells per unit intertubular area. With 
this method of expression, maximum values were found in 10- to 30-day old rats 
before it gradually declined with age to reach the minimum value again in 90-day old 
rats ppigure 3.1603)]. When statistical comparisons were made against the 90-day 
rats which was arbitrarily taken as the reference for adult animals, no significant 
differences in the number of PCNA-positive endothelial cells/unit intertubular area 
could be identified once the animals reached the age of 60-day old or above. 
3.6.2 Changes in blood vessel density 
The changes in testicular blood vessel density were examined among the 
different age groups and again there were differences in the pattem depending on 
whether they were expressed as number per unit testis section area or number per unit 
intertubular area O i^gure 3.17). With the former method of expression, the blood 
vessel density was the highest in 10-day old rats (179.5士6.4 /mm ;^ mean±SE) PFigure 
3.17(A)]. Between 10- and 20-day old rats, the blood vessel density dropped by 
about half(92.5i6.6 /mm^) before it stabilized at around 65-95/mm^ in 30- to 90-day 
old rats. This pattem resembled that of the density ofPCNA-positive endothelial cells 
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Figure 3.16 Changes in the number ofPCNA-positive endothelial cells in the testes of 
rats during postnatal development from the age of 10 to 90 days old. The endothelial 
cell numbers were expressed either as per unit section area (A) or as per unit 
intertubular area (B). 
Data represent mean+SE of 5-6 animals per group. 
*P<0.05, compared with 90-day old rats using Kruskal-Wallis one-way ANOVA on 
ranks followed by Dunn's test. 
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Figure 3.17 Changes in the testicular blood vessel density during postnatal 
development ofthe rats from the age of 10 to 90 days old. The blood vessel density 
was expressed either as per unit section area (A) or as per unit intertubular area (B). 
Data represent mean+SE of 5-6 animals per group. 
*P<0.05, compared with 90-day old rats using Kruskal-Wallis one-way ANOVA on 
ranks followed by Dunn's test. 
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expressed on the same basis of per unit section area fFigure 3.16(A)]. On the other 
hand when the blood vessel density was expressed as number per unit intertubular 
area, there was a biphasic change with the first peak in 10-day old rats (624±22/mm^) 
followed by a second peak in 50-day old rats (678±22/mm^). Statistical analyses 
indicated that only the values at these two ages were significantly (P<0.05) higher 
than that in 90-day old rats. 
3.6.3 Changes in serum testosterone concentration, testis weight and testicular 
intertubular area 
Due to the difficulty in collecting enough sera for radioimmunoassay, serum 
testosterone concentration was not determined in 10-day old rats. Results indicated 
that there were no significant differences in serum testosterone concentration in 20- to 
>90-day old rats. The testis weights of younger animals (10- to 30-day old rats) were 
missing since their testes were fixed by whole body perfusion and fresh weights could 
not be measured. When comparing among the other age groups, the testis weight 
increased with the age of the animals until between 60- and >90-days old, it stabiUzed 
at the values found in adult animals (Table 3.6). Statistical tests indicated that there 
were no significant differences in the testis weight among the 60-, 70- and >90-day 
old rats. As for the percentage of testis section area occupied by intertubular tissue, 
the maximum value was found in 10-day old rats before it fell gradually to 
significantly (P<0.05) lower values found in 50- to >90-day old rats. 
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10d 20d 30d 40d 50d 60d 70d >90d 
^ f ^ f 3.628 3.736 3.416 Paired Testis 士 士 土 士 士 
Weight - - - 0.0*06 0 . 0 8 6 。 工 口 0.114 0.080 
( — (n=5) (n=5) “ “ (n=5) 
Percentage 
testis section 28.74 18.19 16.82 16.68 13.63 12.92 13.88 14.04 
area occupied 土 士 土 士 士 土 士 士 
by 1.33* 1.39* 1.29 0.59 0.38 0.84 0.66 0.91 
intertubular (n=6) (n=5) (n=5) (n=6) (n=6) (n=6) (n=6) (n=5) 
tissues (%) 
3.3 2.0 1.8 2.4 2.0 2.7 3.2 
Serum 士 土 士 士 士 士 士 
Testosterone - Q 8 0.3 0.1 0.3 0.3 0.3 0.5 
(ngAnO (n=5) (n=5) (n=5) (n=5) (n=5) (n=5) (n=5) 
“ 
Table 3.6 Changes in paired testis weight, serum testosterone and percentage testis 
section area occupied by intertubular tissues in rats during postnatal development 
from the age of 10 to >90 days old. 
Data is indicated as mean±SE. 




In the present study, testicular angiogenesis was being investigated in response 
to a single injection ofhCG and during postnatal development in the rat testes. The 
immunostaining for PCNA-labelled proliferating endothelial cells and blood vessel 
density were used as an indices of angiogenesis. Changes in blood vessel density were 
quantified using an image analysis software and related to the number of PCNA-
positive endothelial cells per unit area. 
4.1 hCG-induced endothelial cell proliferation and changes in blood vessel density 
Using immunohistochemical staining for PCNA as a marker of proliferating 
cells, hCG was shown to induce a significant increase in the number of proliferating 
endothelial cells in adult rat testes between 24 and 72 hours after treatment (Au et al., 
1996). Although PCNA is not exclusively a S-phase marker, a recent study using 
bromodeoxyuridine ^BrdU) to label testicular endothelial cells in the S-phase of the 
cell cycle also reported a significant stimulation of endothelial cell proliferation by 50 
EJ hCG 24 hours after a single injection (Collin & BergK 1996). A detail time course 
study performed here revealed that following a single injection ofhCG, the number of 
proliferating endothelial cells increased and then returned back to basal levels over a 
period of within 7 days, and the maximum increase was found 48 hours after 
treatment. 
Whether the increased number of PCNA-positive endothelial cell per unit 
testis section area truly reflects an elevated level of testicular angiogenesis has been 
addressed in the present study by quantifying the blood vessel density in the testes of 
these animals. From the results, it can be seen that the peak of endothelial cell 
proliferation is followed 24 hours later by an increase in blood vessel density to reach 
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a maximum. The temporal relationship between the two changes suggests that the 
hCG-induced increase in the number of proliferating endothelial cells is followed later 
by the laying down of new blood vessels, thus finally cumulating in the appearance of 
more blood vessels per unit area within the testis. In addition, most of the PCNA-
positive endothelial cells identified in the present study were found lining the venules 
and capillaries, and these are the sites where the sprouting of new blood vessels 
regularly occurs. 
It should be noted that a single injection of hCG did not produce a sustained 
increase in the testicular blood vessel density as it reached its maximum after 3 days 
and then returned back to normal levels 7 days after treatment. This would imply that 
the formation of new blood vessels was accompanied later on by the dissolution of 
some of the new blood vessels. The loss of these vessels may involve endothelial cell 
apoptosis which is occasionally seen in normal testes and has been considered as one 
of the two major forces (the other being cell proliferation) responsible for the 
continuous remodelling of the testicular microvasculature (Collin & Bergh^ 1996). 
Alternatively, as what has been found during the lutolysis of the corpus luteum, the 
newly formed blood vessels may regress by gradual foreshortening, rounding and 
finally detachment of endothelial cells without undergoing apoptosis (Augustin et al., 
1995). 
In the past, many studies have reported the use of the proliferation index (ratio 
of PCNA-positive endothelial cell nucleiAotal number of endothelial cell nuclei 
counted x 100，i.e. percentage ofpositive cells) as a marker of angiogenesis (Goodger 
& Rogers 1993; Heron & Rakusan 1995; Kawanami, et al., 1995; Burke, Lehmann-
Bruinsma & Powell 1995; Heron, et al., 1997). However, others have relied on the 
use of PCNA-positive endothelial cell number as a marker of vascular proliferation 
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(Soini, et al., 1996; Nanji, et al., 1994; Nanji & Tahan^ 1996; Yamamoto, et al., 
1997). In the present study, since the testis size was not very much affected by hCG 
stimulation as indicated by the relatively small changes in testis weight, it was 
therefore possible to assume that the total number of endothelial cells per unit section 
area remained relatively constant. Thus monitoring the changes in the number of 
PCNA positive endothelial cells per unit section area would yield almost identical 
information as using the proliferation index (as defined above). 
The vascular effects ofhCG on the testis has been well-documented (reviewed 
in the "Introduction"). In adult rats, the testes respond to a single injection of hCG 
with a decrease followed by an increase in blood flow, and an inflammation-like 
reaction of polymorphonuclear leukocytes infiltration and vascular permeability 
increase (Sharpe, 1979; Setchell & Sharpe, 1981; Sharpe & Cooper，1983; Widmark, 
Damber & Bergh, 1986; see review by Bergh, Damber & Widmark，1988). The last 
effect results in the accumulation of interstitial fluid which could explain why in the 
present study, the testis weight of these animals was significantly increased at 16-24 
hours post-hCG. All the vascular changes induced by hCG do not occur immediately. 
The initial decrease in testicular blood flow and the start of the PMN infiltration begin 
4-6 hours after hCG injection (Bergh, Damber & Widmark, 1988). Increases in 
testicular blood flow and vascular permeability are reported to occur 16-20 hours 
post-hCG (Setchell & Sharpe，1981). These contrast the serum testosterone response 
which shows a marked increase as early as 2 hours post-injection OHodgson & de 
Kretser, 1982). In the present study, significant increases in the area density of 
PCNA-positive endotheUaI cells and blood vessel density were observed at 1 day and 
3 days post-hCG, respectively. These findings would suggest that the hCG-induced 
vascular changes do not result from a direct action of this hormone on the testicular 
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vasculature. In fact, no LH/hCG receptors have been found in testicular blood vessels 
or on the surface ofvascular endothelial cells. Thus the vascular effects ofhCG are 
Ukely to have been produced indirectly through the release of other mediators from 
within the testis, and time is needed for the generation of these mediators to cause the 
observed changes. 
The present findings confirm that a single injection of 100 KJ hCG induces a 
typical biphasic serum testosterone response, which is in line with a few earlier studies 
OHodgson & de Kretser 1982; Hodgson & de Kretser 1984). However, correlation 
analysis indicated that there was no significant temporal relationship between the 
changes in serum testosterone levels and the density of PCNA-positive endothelial 
cells in testis section. The maximum increase in endothelial cell proliferation was 
observed 2 days after hCG stimulation when the serum testosterone was at its nadir 
between the two peaks. Thus the hCG-induced endothelial cell proliferation in the 
testis does not appear to have resulted from the increase in testosterone production by 
the Leydig cells. 
4.2 Role of Leydig cells in hCG-induced endothelial cell proliferation in adult rat 
testis 
The present study demonstrates that destroying the Leydig cells by EDS 
treatment completely abolishes the increase in the number of PCNA-positive 
endothelial cells induced by hCG. The fact that vehicle-DMSO treatment did not 
significantly affect the endothelial cell response to hCG would indicate that the effect 
due to EDS is specific. Furthermore, since EDS (or DMSO) has no effect on the 
number of PCNA-positive endothelial cells under basal state (without hCG 
stimulation), these ceU proliferation may represent normal turnover of this cell type 
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within the testicular vasculature, and they are not influenced by hormonal changes 
such as low intratesticular and circulating levels of testosterone induced by EDS 
treatment. 
The above findings are in line with the fact that Leydig cells represent the only 
cell type within the testis that express LH>liCG receptor. Also the Leydig cell is a 
source of several angiogenic factors including VEGF and bFGF (see ‘Introduction，). 
In a study that examined the efFect of testicular grafts in rabbits, it was found that only 
those testicular tissues containing interstitial cells would induce an elaborate growth 
ofblood vessels around the grafts O^illiams, 1949). More recently, the above study 
was repeated by transplanting interstitial cells or seminiferous tubule segments under 
the kidney capsule and observed the development of a prominent vascular network 
around the interstitial cell grafts but not the tubule grafts (Collin & Bergh^ 1996). 
The authors of the latest study proposed that VEGF secreted by the Leydig cells 
together with other inflammation mediators are most likely involved in producing the 
hCG-induced endothelial cell proliferation in the testis. This would agree with the 
possible role of VEGF in mediating hormonally-regulated angiogenesis in other 
endocrine glands such as the ovary and the thyroid (reviewed in the ‘Introduction，). 
Despite the evidence in support of the participation of Leydig cells in 
producing the hCG-induced endothelial cell proliferation, the role of VEGF remains 
unclear. In EDS-treated testes, although VEGF immunoreactivity is lost from the 
testicular interstitium, the ones present in Sertoli cells and vascular smooth muscle 
cells remain (Au et al., 1997). Nevertheless, hCG-induced endothelial cell 
proliferation was completely abolished in EDS-treated testes. Thus it is unlikely that 
VEGF from other cellular sources within the testis (e.g. Sertoli cells, vascular smooth 
muscle cells) would be involved or could compensate for the deficiency resulted from 
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the removal of Leydig cells. Furthermore, in adult rats that received chronic 
treatment with the testosterone implants, the levels of hCG-induced endothelial cell 
proliferation in the testes remain indistinguishable from those present in normal 
animals despite a very low level of VEGF immunoreactivity present in these highly 
regressed Leydig ceUs. It can be argued that the loss ofVEGF immunoreactivity from 
the Leydig cells ofthe testosterone-implanted animals only reflects a reduced cellular 
content (or storage) of this peptide but not its synthesis or release in response to hCG. 
Furthermore this may have been compensated by an increased synthesis of VEGF (as 
suggested by stronger immunostaining) from the Sertoli cells. The answers to the 
above questions would have to come from studies examining the Leydig cell VEGF 
mRNA expression and peptide secretion in these animals. Nonetheless, it is possible 
to conclude that the hCG-induced endothelial cell proliferation in adult rat testes is 
critically dependent on the presence but not so much the functional state of the Leydig 
cells, and the involvement of Leydig cell-derived VEGF in this process cannot be 
entirely ruled out. 
Besides VEGF, other inflammation mediators and/or angiogenic factors from 
pro-inflammatory cells may also participate in stimulating endothelial cell proliferation 
in the testis (Collin & Bergh^ 1996). Indeed in the present study, there was an 
association between increased endothelial cell proliferation in response to hCG and an 
inflammation-like reaction as indicated indirectly by an increase in testis weight from 
the accumulation of testicular interstitial fluid. This could be observed in the testes of 
normal rats and rats that received testosterone implants, but not those animals treated 
with EDS to deplete the Leydig cells. At present, it remains unclear what 
inflammation mediators andA)r other angiogenic factors are involved and whether they 
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are derived from Leydig cells, testicular macrophages or the infiltration of PMN 
leukocytes. 
The present data also indicate that the spermatogenic activity within the 
seminiferous tubules or the mass of the tubules has no significant contribution towards 
determining the proliferative response of vascular endothelial cells to hCG 
stimulation. Such reasoning can be drawn from the studies of animals bearing the two 
doses oftestosterone implants and from the EDS-treated group. In the 3 cm-implant 
group, testis weight feU by one-third due to inadequate hormonal support to maintain 
normal spermatogenic activity within the seminiferous tubules. Despite the loss of 
tubule mass, the hCG-induced endothelial cell proliferation remained insignificantly 
affected when compared with the 25 cm-implant group or the normal control. This 
contrasts strongly against the acute treatment by EDS when at 4-5 days after 
treatment, the proliferative response of endothelial cells to hCG stimulation 
completely disappears despite an insignificant fall in testis weight. Thus there is no 
fixed relationship between the levels ofhCG-induced endothelial cell proliferation and 
the tubule mass or the level ofspermatogenic activity within the tubular compartment. 
As earlier pointed out, comparisons of endothelial cell proliferation per unit 
section area among different treatment groups and the control have to base on the 
assumption that the testis size remained little affected. However in this experiment, 
animals bearing the 3 cm testosterone implant had a reduced level of spermatogenesis 
due to inadequate hormonal support, and the shrinkage of the tubular compartment 
had exaggerated the value ofPCNA-positive endothelial cell number per unit section 
area. As a method of adjustment, the number ofPCNA-positive endotheial cells was 
instead related to per unit intertubular area. 
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As previously discussed in section 4.1, the testosterone response to hCG does 
not appear to be linked to the hCG-induced endothelial cell proliferation. This was 
again confirmed in the study of rats bearing the testosterone implants. In these 
animals, the testosterone response to hCG stimulation was compromised due to the 
chronic suppression ofLeydig cells by the exogenous testosterone, and a small but 
significant increase in serum testosterone was observed only in the 25 cm-implant 
group. However, despite the large differences in circulating testosterone levels 
achieved in the two implanted groups, their stimulated increases in endothelial cell 
proliferation (when expressed as per unit intertubular area) were almost identical. 
These observations suggest that the hCG-induced endothelial cell proliferation is 
mediated by Leydig cell products other than steroids. 
4 3 Role oftesticular macrophages in hCG-induced endothelial cell proliferation in 
adult rat testis 
hCG-induced endothelial cell proliferation (at 1 day and 2 days post-hCG) in 
adult rat testes was enhanced following activation of testicular macrophages by latex 
beads. The two treatments appear to synergize with each other since their combined 
actions resulted in nearly twice the sum of their individual effect in producing an 
increase in the density ofPCNA-positive endothelial ceUs (pQV unit section area). The 
mechanism of such interaction remains unclear but it is possible that angiogenic 
factors from Leydig cells and activated macrophages (as reviewed in the 
‘Introduction，）may synergize with each other in stimulating the proliferation of 
endothelial cells. It has been reported that cultured macrophages activated by latex 
beads phagocytosis are able to induce vascular proUferation (Polverini et al., 1977). 
In addition, testicular macrophages and Leydig cells are known to exhibit significant 
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structurally and functionally interaction O^ller, Bowman & Rowland，1983; Bergh, 
1985), and thus activated macrophages may potentiate the hCG-induced Leydig cell-
mediated vascular changes through a paracrine mechanism. Kerr & Sharpe (1989) 
have used the same method of activating testicular macrophages by latex beads and 
reported that the inflammation-like reaction ofthe intertubular tissue associated with 
hCG administration is enhanced. Therefore it is also possible that the angiogenic 
response is potentiated by the higher levels of inflammation mediators originating 
from the macrophages and the infiltration ofPMN leukocytes CLeibovich et aL, 1987; 
Sunderkotter etal., 1991;Jackson etaL, 1997). 
In the present study, testicular macrophages were activated by an 
intratesticular injection ofpolystyrene latex beads and the effect was studied 4-5 days 
after treatment. However, even under basal condition (in the absence of hCG 
stimulation) and with the injection ofsterile saline (in the sham-operated control), the 
procedure alone already induced an artifactual increase in the number of PCNA-
positive endothelial cells. This could have resulted from the reaction to tissue damage 
caused by the passage of the needle, and would also explain why this artifactual 
stimulation appeared to subside with time after treatment. 
Based on the results ofthe above study, it would appear that the hCG-induced 
endothelial cell proliferation will be compromised after the depletion of testicular 
macrophages. Also, this would be expected based on the fact that tissue macrophages 
are a source ofangiogenic factors and pro-inflammatory mediators (Sunderkotter et 
“/.，1991) and its depletion has previously been shown to reduce the rate of 
angiogenesis during wound healing O^eibovich & Ross, 1975). However, in the 
present study, depletion oftesticular macrophages by CkMDP-lp treatment was found 
to have potentiated the effect of hCG in producing an even larger increase in the 
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number of PCNA-positive endothelial cells in the testicular vasculature. The same 
procedure has previously been shown to enhance the hCG-induced inflammation-like 
response OBergh, Damber & van Rooijen, 1993). Indeed in the present study, many 
PMN leukocytes could still be found in the interstitium of the macrophage-depleted 
testes 48 hours post-hCG, whereas in normal testis, most of the PMN leukocytes 
would have disappeared and their number returned back to pre-treatment levels 32 
hours post-hCG OBergh et a!.，1986). As earlier proposed by Bergh & his coworkers 
(1993b)，the loss oftesticular macrophages may have removed an inhibitory influence 
that limits the development of the inflammation-like reaction induced by hCG 
stimulation. Secondary to the above changes, the prolonged infiltration and/or 
accumulation of PMN leukocytes may have provided an alternative source of 
angiogenic factors or inflammation mediators ^Gbbey et al., 1994; Ferrara, 1995; 
Gaudry et al, 1997) to potentiate the endothelial cell proliferation caused by hCG. 
Nonetheless, since not the fuU complement of leukocyte subtypes (i.e. macrophages 
and PMN leukocytes) would be available, thus it is not surprising to find that 
testicular macrophage depletion is less effective when compared with testicular 
macrophage activation in potentiating the hCG-induced endothelial cell proliferation 
in the testicular vasculature. 
In this study, although Cl2MDP-lp (or PBS-lp for the sham-operated control) 
was also given by intratesticular injection, no artifactual increase in endothelial cell 
proliferation was observed under the basal state (without hCG stimulation). This 
could be related to the fact that the intratesticular injection was given at least 2 weeks 
prior to the tissue collection for the study of endotheUaI cell proliferation and any 
tissue damage or reaction would have already subsided after this period. 
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4.4 Testicular angiogenesis during postnatal development 
The developmental changes in testicular angiogenesis during the postpartum 
life of rats from the age of 10- to 90-day old were examined using the methods of 
PCNA immunostaining to identify proliferating endothelial cells and ink perfusion to 
label the testicular blood vessels. Depending on the method of quantification and 
expression, different patterns of changes have emerged. Normalizing the number of 
PCNA-positive endothelial cells and blood vessels against per unit section area would 
not give an accurate picture ofthe changes due to the fact the intertubular area where 
the blood vessels are located does not constitute a fixed percentage ofthe total testis 
section area. During the development of the testis, the initiation and final 
establishment of spermatogenesis inside the seminiferous tubules has led to a rapid 
expansion in the size ofthe tubular compartment initially, before it gradually stabilizes 
to the level found in adult animals. As a result, there is an age-related decrease in the 
percentage of testis section area occupied by the intertubular tissues as illustrated in 
the present study. The difference in this value between immature and adult testes 
(>60 day-old) is not particularly marked and statistically higher percentages could 
only be demonstrated for animals at the age of 20-day old or younger. Similar 
findings have previously been reported based on the volume density of seminiferous 
tubules in rats (Gazdzik, et al., 1985; Gaytan et al, 1986; Kerr, Risbridger & Knell， 
1988). This value does not appear to change much during postnatal development 
although it forms a lesser proportion of the testis mainly prior to 20-day old, when 
compared with that in the adult. Thus in the present study, when the number of 
PCNA-positive endothelial cells or blood vessels was expressed over per unit section 
area, there is a trend for this value to decrease with the age ofthe animals. 
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When the number ofPCNA-positive endothelial cells was normalized against 
per unit intertubular area, the maximum values were found in the testes of 10- to 30-
day old rats. These data agree extremely well with earlier studies carried out using 
other methods ofquantifying proliferating endothelial cells in rats, hamsters and mice. 
In an earlier study performed on Sprague Dawley rats, a marked increase in the total 
number ofendothelial cells in the testis (as determined using the stereological method) 
was found between Day 7 and Day 28 post partum ^Iardy, Zirkin & Ewing, 1989). 
When tritated thymidine was used to label the proliferating endothelial cells, high 
labelling index was found between Day 14 and Day 24 post partum. In the golden 
hamster, testicular angiogenesis as indicated subjectively by the morphological 
appearance of endothelial cell migration was found to be most conspicuous in the 
testes of 8- to 25-old animals 0^ayerhofer & Bartke，1990). In mice, the total 
number of endothelial cells as determined also using the stereological method, was 
found to increase significantly from the age ofDay 11 to Day 28 (Vergouwen et al, 
1993). 
Following a marked increase in the density ofPCNA-positive endothelial cells 
(per unit intertubular area) in the testes of 10-30 days old rats, the blood vessel 
density (expressed also on the same basis of per unit intertubular area) was found to 
reach its second peak in 50-day old rats. The first peak was found in 10-day old rats 
and this could be related to a very small size of the testis at this age. After 
spermatogenesis and Leydig cell development begin at the age of 19-20 days and 15-
18 days post partum, respectively, both the tubular and intertubular compartments 
rapidly expand in size and this may explain why the blood vessel density in the testis 
actually fell in animals between the age of20- and 40-day old. The marked increase 
in density ofPCNA-positive endothelial cells was followed later on by a peak ofblood 
90 
vessel density since time is required for new blood vessels to be laid down after an 
earlier step involving endothelial cell proliferation. In the present study, using ink 
perfusion followed by image analysis, it was not possible to establish whether the 
increase in vessel numbers is due to capillaries, venules or arterioles. Nevertheless, 
the results appear to agree chronologically with the onset time for the development of 
intertubular and peritubular capillary network at the age of 20-35 days as revealed 
using an angiographic method ^Comamo, 1967a). The cause for a decrease in 
testicular blood vessel density in animals after the age of 50-day old remains unclear. 
Whether this truly represents a regression of blood vessels or only the density was 
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